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Abstract 
Iron oxide nanoparticles have been intensively studied in biomedical applications 
because of their low toxicity, biocompatibility and their high response to an external 
magnetic field. Recently, such particles are considered as potential candidates for 
many advanced applications such as hyperthermia, magnetically guided drug delivery 
and release and theranostic nanomedicines. However, most of these studies are ended 
at the preclinical step due to the limitations of current nanomaterials and numerous 
challenges at different stages of the development of these nanomaterials. So, the search 
of new versatile nanostructures which might be exploited in human therapy is urgent.  
In this dissertation, we focus on the functionalization of iron oxide-based nanoparticles 
and the utilization of the obtained multifunctional core-shell nanostructures for several 
biomedical applications.  
In the first part, we study the functionalization of iron oxide nanoparticles with various 
coating agents. The functionalization renders particles water-dispersible and provides 
functional moieties such as polyethylene glycol, carboxyl and amino groups, gold and 
silica shells, and fluorescent tags. With a wide range of functionalities, the particles are 
beneficial for various purposes. Carboxyl-functionalized iron oxide nanoparticles were 
studied as bio-entity coupling agents while amine functionalization was used as a first 
step for gold coating preparation.  
Core-shell nanostructures possess many interesting properties as compared with single 
compositions because of the interaction between each component. Therefore, we 
synthesized (multilayer) core-shell nanoparticles in order to combine several functions 
into one single structure: magnetic properties, plasmonic properties, mesoporous silica 
properties and fluorescent properties. In particular, we investigated the utilization of 
these core-shell nanostructures as drug release carriers. The payload was covalently 
bound to the particles, then its controlled release was induced by an oscillating 
magnetic field. Finally, we describe the utilization of the core-shell nanoparticles as 
nonlinear optical imaging agent.  
 
 v 
Samenvatting 
Ijzeroxide nanodeeltjes kennen heel wat biomedische toepassingen. Met hun lage 
toxiciteit, biocompatibiliteit en superparamagnetische eigenschappen kunnen ze 
beschouwd worden als potentiële kandidaten voor toepassingen zoals magnetisch 
geïnduceerde hyperthermie en magnetische drug delivery. De laatste jaren is er dan 
ook heel wat onderzoek verricht in dit domein, maar de meeste studies worden echter 
beëindigd bij de preklinische stap als gevolg van de beperkingen van de huidige 
nanomaterialen en talrijke uitdagingen in verschillende stadia van de ontwikkeling van 
deze nanomaterialen. Dus, de zoektocht naar nieuwe veelzijdige nanostructuren die 
kunnen gebruikt worden voor biomedische toepassingen is zeer actueel en relevant. 
In dit proefschrift richten we ons in eerste instantie op de functionalisering van 
ijzeroxide gebaseerde nanodeeltjes om multifunctionele kern-schil nanostructuren te 
bereiden voor meerdere biomedische toepassingen. We bestudeerden de 
functionalisering van ijzeroxide nanodeeltjes met diverse materialen zoals 
polyethyleenglycol, carboxyl- en aminogroepen, goud en silica schillen, en 
fluorescerende labels. Het maakt de deeltjes niet alleen waterdispergeerbaar maar 
levert ook verschillende andere functionaliteiten. Kern-schil nanostructuren 
combineren immers niet alleen de eigenschappen van de samenstellende materialen, 
maar kunnen ook nieuwe eigenschappen vertonen. In dit werk ontwikkelden wij kern-
schil nanostructuren die  magnetische, plasmonische, mesoporeuze en fluorescerende 
eigenschappen combineren. Dit illustreerden we vervolgens mbv twee toepassingen, 
nl. magnetisch gecontroleerde drug release en multifoton visualisatie. 
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Chapter 1                           
General introduction to magnetic 
core-shell nanoparticles and their 
biomedical applications 
Today, the development of economics and science enables people to explore new 
lands, going deep underground, flying into space to seek life beyond the Earth and 
investigate small particles like atoms, molecules, nano-sized materials. We talk about 
new technology every day: smartphones, laptops, self-driving cars, and some of them 
have drastically changed the way we are living. However, the cost we have to pay is 
unsustainable development, especially in the third world countries, resulting in many 
environmental disasters including global warming, air pollution, water pollution. 
Consequently, people also face both old and new health problems. There are still many 
incurable diseases (Ebola, HIV/AIDS, cancer), new viruses (or virus evolution) and  
contagious diseases. One of the most dangerous diseases is cancer, and many research 
efforts have been devoted to curing cancer.  
In this chapter, we will briefly discuss cancer and applications of nanotechnology 
(particularly magnetic core-shell nanoparticles) in biomedicine in general and cancer 
treatment in particular. Because these advanced applications rely on the unique 
properties of multifunctional nanoparticles (MuNPs), the structure of MuNPs and their 
properties will also be presented. At the end of this chapter, we give an overview of 
several characterization methods of nanomaterials.  
Generally, this dissertation focuses on the design of different types of MuNPs based on 
a magnetic iron oxide core, various nanoshells and functionalization. Several 
applications of MuNPs in the biomedical field were also explored, suggesting that 
these materials can be potential candidates for future applications in disease/cancer 
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diagnostic and therapy such as biomedical imaging or drug delivery and release. First 
of all, we need to know what is cancer and why cancer is so dangerous? 
1.1 Overview of cancer  
What is cancer?  
Cancer is a very common condition and a serious health problem. It is estimated that 
more than one in three people will develop some forms of cancer during their life [1]. 
So what is cancer? Cancer is a group of diseases that all share an uncontrolled division 
of abnormal cells in some part of the body. Normally, cells in the body grow and 
divide for a certain time and then stop growing and dividing. They only reproduce 
themselves when the body needs them, for example, for replacement of old cells. In 
the case of cancer, the cancer cells are able to ignore signals that tell the cells to stop 
dividing and therefore these cells grow and reproduce in an uncontrolled manner. They 
can then invade other normal tissues and organs, and eventually spread throughout the 
body. The extra cells caused by cancer may form tumors. Based on the characteristics 
of tumors, we can classify cancer into 2 types: malignant tumors and benign tumors. 
Type of cancer: malignant tumor and benign tumor 
Cancer can start almost everywhere in the human body, so there are over a hundred 
distinct types of cancer, which are mainly different in their behavior and response to 
treatment. Most cancers form masses of tissue called tumors (except in case of 
leukemias). A tumor can come in two forms: benign and malignant. A benign tumor is 
a cancerous tumor that remains confined to its original location and demonstrates 
limited growth. It does not spread into, or invade nearby tissues. Benign tumors are 
usually not life threatening. They may be removed surgically. After being removed, 
they usually do not grow back. 
A malignant tumor, however, is able to invade and spread to surrounding normal 
tissue, resulting in destruction of healthy tissue and organs. In addition, the capability 
of traveling from the initial tumor site to other parts of the body known as metastasis 
makes malignant tumors resistant to localized treatments such as surgery. Therefore, 
they become more dangerous.    
Although there are many kinds of cancer, only a few occur frequently (Table 1.1). 
Cancers of 10 different body sites account for more than 75% of all cancers. 
How dangerous is cancer? 
To illustrate how dangerous cancer is, one could consider the following data: Every 
year, more than a million cases of cancer are diagnosed in the United States, and the 
number of Americans that die of cancer can reach 500,000 [2]. In an estimate, 196,900 
new cases of cancer and 78,000 deaths from cancer occurred in Canada in 2015. 
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Cancer is the leading cause of death in Canada and is responsible for 30% of all deaths  
(see Fig. 1.1) [3]. In Vietnam, 110,000 new cases of cancer are reported annually with 
death rate of 73 % - one of the highest rates in the world. According to WHO, the 
world's average mortality rate of cancer patients is just 59.7 %: the average death rate 
in the developing countries is 67.8 % whereas in developed countries, it is much lower, 
only 49.4 % [4].    
Why is cancer so dangerous? 
There are four main reasons why cancer is a deadly disease: 
i) Invading normal tissues and organs: The rapid and uncontrollable growth of 
cancer cells, leads to less room for the cells we need (e.g., red and white blood cells). 
Furthermore, the tumor also uses a lot of blood, and as a consequence the hemoglobin 
in the blood can decrease drastically. 
ii) Metastasis: Metastasis is a process whereby cancer cells travel from the initial 
tumor site to other parts of the body. This spread of cancer cells make cancer become a 
more serious health problem. For example: initially, melanoma (see Fig. 1.2, a cancer 
of pigmented cells) can arise in the skin, but some of the cancer cells can enter the 
bloodstream and spread to distant organs such as the liver or brain. Cancer cells in the 
liver would be called metastatic melanoma, not liver cancer. Melanoma cells growing 
in the brain or liver can disrupt the functions of these vital organs and are potentially 
life threatening:  
iii) The limitation of current treatments: Current treatments including 
chemotherapy, radiation therapy, surgery, gene therapy, immunotherapy face many 
difficulties because of the metastasis of cancer. These therapies, if successful, might 
Table 1.1: Ten Most Frequent Cancers in the United States (source: American 
Cancer Society, Cancer Facts and Figures—2000 [2]). 
Cancer site Cases per year Deaths per year 
Breast 184,200 (15.1%) 41,200 (7.5%) 
Prostate 180,400 (14.8%) 31,900 (5.8%) 
Lung 164,100 (13.4%) 156,900 (28.4%) 
Colon/rectum 130,200 (10.7%) 56,300 (10.2%) 
Lymphomas 62,300 (5.1%) 27,500 (5.0%) 
Bladder 53,200 (4.4%) 12,200 (2.2%) 
Uterus 48,900 (4.0%) 11,100 (2.0%) 
Skin (melanoma) 47,700 (3.9%) 7,700 (1.4%) 
Kidney 31,200 (2.6%) 11,900 (2.2%) 
Leukemias 30,800 (2.5%) 12,100 (2.2%) 
Subtotal 933,000 (76.5%) 368,800 (66.8%) 
All sites 1,220,100 (100%) 552,200 (100%) 
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Figure 1.1: Proportion of deaths due to cancer and other causes, Canada, 2011. 
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Figure 1.2: Cancer cells (green dots) of a tumor, arising in the skin, can enter the 
blood stream and spread to distant parts of the body such as liver, brain (source: 
national cancer institution, USA, www.cancer.gov). 
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extend the life time of patients but we never know whether cancer will come back 
again one day   when the metastatic cells grow to become a tumor somewhere in the 
body. In addition, these treatments are not specific. They do not only kill cancer cells 
but also kill healthy cells and tissue. 
iv) Late diagnosis: generally, a long time is required for cancer to develop. The period 
between the exposure to a carcinogenic agent and cancer actually developing is usually 
many years (up to 30 years). This time frame is called the latency period, or lag time. 
On the contrary, when the number of cancer cells is large enough, cancer cells grow 
very fast. Therefore, the early stage of cancer quickly turns to the late stage. For this 
reason, when someone is diagnosed with cancer, he/she might be in the final stages of 
cancer with a large number of cancer cells in the body. Therefore, the treatment is 
often not as efficient as expected. 
1.2 How nanotechnology can help with therapeutic 
applications 
1.2.1 Tumor targeting agents – a powerful tool of 
nanotechnology 
As mentioned above, the difficulties in cancer treatment are not only the requirement 
for specific medicines but also a low efficiency of the treatment. Current treatments 
 
Figure 1.3: Schematic of cancer development. Cancer starts when normal cells 
undergo a genetic change when they are exposed to a cancer risk, then each cancer 
cell is divided incessantly into two cancer cells and group together to form a 
tumor. Source: Canadian cancer society (www.cancer.ca).  
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include surgery chemotherapy, radiation therapy, gene therapy, hyperthermia, 
immunotherapy, but each method has its own limitations [5], [6]. The main limitations 
of current cancer therapies are that they are far too invasive, painful, toxic and 
associated with too many acute and chronic side effects. Furthermore, the biggest 
drawback of cancer diagnostics and therapy is that healthy tissues surrounding the 
tumor are also affected by treatment, leading to a weakened immune system. In fact, 
there are many cases where the cancer patients die shortly after their cancer treatment 
because the immune system is severely weakened.  
For this reason, the most important requirement is the design of tumor targeting agents 
that can carry drugs directly and specifically to tumors. In this way, the treatment does 
not need a large dose of drugs and the healthy tissues do not significantly suffer from 
the treatment.  
To achieve this goal, cancer cells need to be identified among trillions of healthy cells 
in the body. In other words, very specific binding between cancer cells and therapeutic 
agents is required. At the beginning of the 20th century, Paul Ehrlich defined the term 
“magic bullet” referring to the ability of an antibody to specifically target the surface 
of cells with great specificity [7]–[9]. Ideally, a ‘‘magic bullet’’ consists of a 
nanometer-sized delivery platform that is able to specific the targeting cancer cells, 
avoiding premature fragmentation and degradation [10]. The platform also facilitates 
the delivery of concentrated drug across the cell membrane. Thanks to the 
development of nanotechnology, nowadays antibody conjugated MuNPs can be used 
widely as tumor targeting agents because of the specific interaction between antibodies 
and antigens in cancer cells. Similar to the key-lock situation where only one key is 
able to open the lock, the antibody would exclusively and specifically bind to the 
Table 1.2: FDA approved cancer targeting antibodies and small molecules 
Name Brand name Type Cancer type 
Bevacizumab Avastin Antibody Colorectal, breast 
non-small cell lung,  
Trastuzumab Herceptin Antibody Breast 
Tositumomab Bexxar Antibody Lymphoma 
Rituximab Rituxan Antibody Lymphoma 
Imatinib Gleevec Small molecules Leukemia, 
Gastrointestinal 
Bortezomib Velcade Small molecules Myeloma, 
Lymphoma 
Gefitinib Iressa Small molecules Non-small cell lung 
Sorafenib Nexavar Small molecules Kidney, liver 
Tamoxifen Nolvadex Small molecules Breast 
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tumor [11] (see Fig. 1.4). The specificity of the binding is due to the specific chemical 
composition of each antibody. Antigens are bound to antibodies through weak 
and non-covalent bonds such as electrostatic interactions, hydrogen bonds, Van der 
Waals forces, and hydrophobic interactions [12]. 
It is worth to note that some small molecules also have the same function as antibodies 
in cancer targeting. Table 1.2 shows some of the cancer targeting antibodies/small 
molecules approved for use in human cancer therapy by the Food and Drug 
Administration (FDA) [13]. Besides cancer, this method is also applied widely for 
other diseases and many commercial products based on antibodies were approved by 
the FDA for human therapy [14]. 
For all reasons mentioned above, the tumor targeting nanoparticles play a key role in 
highly efficient therapeutic applications. Antibodies are linkers to connect cancer cells 
and nanoparticles (NPs), whereas the different components of the NPs play exhibit 
many functions, such as providing contrast for imaging, act as a drug delivery/release 
platform, or act as a therapeutic agent. To achieve this multifunctionality, 
nanoparticles of the core-shell type should be ideal. These structures will be discussed  
in the next section, followed by an overview of the applications of tumor targeting 
antibody MuNPs in cancer diagnostic and therapy.  
 1.2.2 Multifunctional nanoparticles 
Nanomaterials are defined as materials with at least one external dimension in the 
range of 1-100 nanometers [15]. Nanoparticles are objects with all three external 
 
Fig. 1.4: A schematic representing the specific interaction between nanoparticle-
bound antibodies and cancer cells. Reprinted with permission from Ref. [9].  
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dimensions at the nanoscale. Fig. 1.5 shows the size range of nanoparticles in 
comparison with other well-known objects such as atoms, molecules, viruses and 
bacteria. The most important characteristics, among many others, on the nanoscale are 
as follows: First, the small size of the particles leads to physical properties that are 
governed by quantum phenomena [16]. Second, the increasing surface area to volume 
ratio leads to an increase in the dominance of the surface atoms of the nanoparticle 
over those in its interior. 
Advanced applications of NPs require multifunctional nanoparticles – particles that 
exhibit different functions. For example, MuNPs in biomedical applications can be 
utilized for many purposes such as an imaging agent, a targeting agent and a 
therapeutic medicine. These particles are often composed of large NPs (≤ 100 nm) at 
the center and functional moieties/molecules/shells which are conjugated to NPs. 
Using large particles allows particles to carry many functional components. Moreover, 
in some cases, bare NPs themselves can also possess many interesting properties and 
acts as a functional component. Some typical bare NPs are magnetic iron oxide 
nanoparticles (IONPs), plasmonic gold NPs and mesoporous silica NPs. 
The first studies of nanomaterials started with single (metallic/metal oxide) NPs 
because these particles showed different properties than bulk materials. Later, 
scientists found that certain types of semiconductor composite NPs performed much 
better in comparison with the single semiconductors [17]–[19]. These results opened a 
new chapter of nanomaterials in which the combination of two or more components 
can lead to the enhancement of their single components  and develop new properties in 
some cases [20], [21]. There are many ways to combine different components into one 
nanostructure, however core-shell nanostructures have been given much more 
 
Fig. 1.5: One dimension of a nanomaterial should be in the 1-100 nm range. As a 
comparison, other typical sizes of everyday objects and organisms are shown. 
Reprinted with permission from Ref. [15]. 
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attention because the maximal interaction between components is achieved in this kind 
of structure.  
Core–shell nanomaterials have a combination of different properties from different 
material compositions in a single particle. Therefore, this kind of nanostructure can 
offer multifunctionality. They represent a novel class of hybrid materials, where 
composition and structure vary in the radial direction [22]. The addition of nanoshells 
brings a number of possibilities and opportunities for different purposes. Some of the 
direct benefits are:  
- Protection: The presence of the shell can protect the core from environmental 
effects, especially in cases where the core is very sensitive [23]–[25]. The 
protection is also required when the cores are toxic (e.g., quantum dot, cobalt 
NPs). In these cases, nanocores are coated by biocompatible ligands in order 
to reduce their toxicity [26], [27]. 
- Reduction of nanomaterial cost: Expensive nanomaterials can be formed as 
shells around inexpensive core nanomaterials. This is particularly useful in 
catalysis [28], [29].  
- Enhancement of the properties of single components: The dimensions and 
composition of the shell can be modulated in order to influence the properties 
of the core and similarly the core dimensions can be modulated to influence 
the properties of the shell [20], [30]–[32].  
- Surface bio-functionalization: The formation of nanoshells like silica enables 
versatile ways to achieve the surface bio-functionalization that might be 
difficult or impossible to perform on a core surface [25], [33], [34].  
More importantly, multiple functions such as detection and treatment modalities or 
multiple treatment options can be incorporated in a single core–shell particle [35], 
[36]. Although MuNPs are potential candidates for highly efficient human therapy, 
utilization of multifunctional core-shell NPs is relatively new. So far, many in vitro 
and in vivo experiments were carried out and showed promising results, but most of 
them have stopped at preclinical trials [5], [7], [11]. There are only few clinical trials 
reported, including the utilization of IONPs coated with aminosilane for hyperthermia 
treatment of tumors (MagForce Nanotechnologies AG, German company). 
For these reasons, utilization of MuNPs for biomedical applications in general and 
cancer theranostics in particular has been a hot topic and there is still a lot of room for 
development and improvement. Fig. 1.6 shows a possible structure of functionalized 
core-shell NPs for biomedical applications [9]. Depending on the application, different 
kinds of functionalities can be incorporated into a nanoparticle. For example, the 
stealth property of polyethylene glycol (PEG) can help to improve the biocompatibility 
of the NPs and it also increases the circulation time of the NPs [37], [38]. The 
incorporation of an imaging contrast agent (MRI, fluorescent, radionuclide agents) into 
NPs allows the nanostructures to be tracked by imaging techniques [7], 
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[38]. The most common agents that are coupled to NPs are fluorescent dyes, which are 
covalently bound to the NPs. This  functionalization is often used to study the cellular 
uptake of the NPs [7]. Also, immunogenic polymers and several simple and complex 
carbohydrates can provide the immunogenicity for MuNPs [40]. The functionalization 
of NPs with antibodies (or several molecules) can be used for cell targeting [41], [42]. 
The principle is based on the specific interaction of antibodies and antigens on cell. 
pH-sensitive coating agents can be exploited to control the release of drugs which are 
loaded inside NPs [43], [44].  
1.2.3 Tumor targeting antibody conjugated multifunctional NPs 
for cancer therapeutic applications 
Cellular uptake 
Here we discuss how MuNPs can help with cancer diagnosis and therapy. As 
mentioned in Section 1.2.1, the utilization of tumor targeting antibody conjugated NPs 
is the key for the improvement of current theranostics. By using these cancer targeting 
NPs, more particles are able to approach cancer cells. Consequently, the cellular 
 
Figure 1.6: Possible structure of functionalized core-shell nanoparticles for 
biomedical applications. One or some functionalization can be performed, 
depending on the applications of the nanoparticles. Note that the figure does not 
show the actual ratio between particle and functionalities (E.g. antibody). 
Reprinted with permission from Ref. [9]. 
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uptake of these NPs is also increased as compared the uptake of free drug or naked 
nanoparticles [7]. Fig. 1.7 shows two examples of the enhancement of cellular uptake 
for tumor targeting nanoparticles as compared with the cellular uptake for non-
targeting NPs. The bare nanoparticles in these two examples were mesoporous silica 
NPs (MSNPs). The particles were labeled with fluorescent agents, allowing to 
determine the location of tumor targeting NPs by fluorescence microscopy.  
Early disease diagnostics: Many diseases, including liver cancer, can only be 
diagnosed when they are at the very last stage. In this case, surgery is not possible any 
more and other therapies only have limited success. Thus, early diagnosis is required 
and the utilization of MuNPs is a feasible solution [1], [39]. One interesting challenge 
is the search for new enhanced contrast imaging agents (MRI, fluorescent imaging, 
nonlinear imaging). In this way, the sensitivity of current diagnostic methods can be 
 
Fig. 1.7: Examples of the enhancement of cellular uptake for tumor targeted 
MSNPs. (a) Fluorescence microscopy images of particles taken up by a metastatic 
cancer cell line MDA-MB435, showing the enhancement of cellular uptake for 
tumor targeted MSNPs (lower) compared to particles without any targeting group 
(upper). Green/yellow fluorescence indicates FITC-labeled MSNPs (FITC: 
fluorescein isothiocyanate). (b) Fluorescence microscopy images showing 
significant increase in cellular uptake for tumor targeted MSNPs in KB-V1 cancer 
cells (lower). MSNPs were loaded with anticaner drug Doxorubicin which also 
acts as red fluorescent agent. Adapted with permission from Ref. [7]. 
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significantly improved. For example, current agents in MRI techniques are based on 
Gd
3+
 chelates with high stability. These small gadolinium containing molecules work 
by shortening the T1 relaxation time of atoms (such as water protons) in body tissues, 
therefore improve the visibility of tissues in MRI scanner. However, these MRI 
methods are not sensitive enough to observe unusual tissue in the early stage. 
Moreover, gadolinium is also toxic: Gd-based MRI agents cause blood-brain barrier 
defects [45].  Contrary to small Gd-based molecules, several nanoparticles such as 
superparamagnetic IONPs, superparamagnetic iron platinum NPs have been shown to 
be sensitive MRI agents because of good T2 relaxivities [46]–[48]. These particles 
work by reducing the T2 signals of absorbing tissues.  
Besides disease diagnostics based on imaging agents, there are other methods based on 
the determination of specific compounds/bio-entities generated by the presence of the 
disease. At the early stage of any disease, the amount of pathogenic entities is too 
small for current assays to determine. Then, MuNPs do not interfere in the assay 
method but increase the concentration of these entities. The most convenient method is 
magnetic separation with the aid of antibody conjugated NPs. For example, Legionella 
pneumophila bacteria, known to cause the Legionnaires’ disease or legionellosis, a 
serious form of pneumonia [49], [50], can be magnetically separated by using antibody 
conjugated IONPs [50]. In this way, the detection limit of current methods is 
significantly increased. This strategy can be exploited in pre-concentration protocols 
for numerous other pathogens.  
Cancer therapy 
Current cancer treatments include surgery, hyperthermia, chemotherapy, radiation 
therapy, surgery, gene therapy and immunotherapy. Except for surgery, all treatments 
can be significantly improved when combining them with tumor targeting 
nanoparticles.  
Hyperthermia:  
Nanomedicines that relied on hyperthermia were the first to be used in cancer therapy. 
The approach involves raising the temperature of the local environment of a tumor 
resulting in a change of the physiology of diseased cells finally leading to apoptosis 
[51]. Nanoparticles can be strongly heated under the influence of an oscillating 
magnetic field (in case of magnetic core) [52] or  light irradiation (in case of plasmonic 
NPs or nanoshells). Cell death can occur when the temperature of the region increases 
above 41 
o
C while necrosis occurs at 50 
o
C and above [5], [13]. 
Targeting drug delivery and release:  
Herein, ‘drug’ can be understood as an specific anticancer medicine or therapeutic 
agent such as a radioactive isotope. The payload is loaded inside MuNPs designed in 
such a way to gradually release the payload or controllably release the payload under a 
physical/chemical stimulus. In the case of very toxic drugs (such as 5-fluorouracil 
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hydroxycamptothecin, docetaxel, and gemcitabine), hiding drugs inside NPs limits the 
exposure of healthy tissue to the  drug and consequently decrease the toxicity of 
therapeutics [53]–[56]. In addition, the efficiency of chemotherapy is improved.     
Moreover, the loading of drugs inside NPs is especially important with water insoluble 
drugs. These drugs show high efficiency against cancer, however their low solubility 
does not allow to transfer a high dose of drugs to tumors. This problem was solved by 
using mesoporous silica shell as the carrier that is able to load high concentrations of 
water insoluble drugs [57]. 
Theranostic nanomedicine:  
MuNPs provide agents for cancer diagnostics and therapy. Moreover, therapy agents 
and diagnostic agents can be present together in the same formulation– named 
theranostic agents [58]. Firstly, the theranostic agents need to consist of a 
nanoparticle core. Secondly, it is essential that there is a tumor targeting ligand present 
as mentioned in Section 1.2.1.  Moreover, theranostic NPs often consist of a diagnostic 
imaging domain and therapeutic agents [59] (see Fig. 1.8). Theranostic agents also 
need to be smaller than 150 nm, because bigger particles will not penetrate into tissue 
and they will also be recognized as an alien object by the immune system.  
Both organic and inorganic NPs can be used as the core to build the theranostic NPs. 
Among them, polymers, lipids, proteins (organic materials) and iron oxide, gold, silica 
(inorganic materials) are the most commonly used [7] . Interestingly, in the case of 
 
Fig. 1.8: Schematic of a theranostic agent, including a nanoparticle at the core, an 
imaging component, targeting ligands, and therapeutic agents. Reprinted with 
permission from Ref. [59]. 
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hyperthermia treatment, the iron oxide core or gold NPs/nanoshells do not only act as 
therapeutic agent but also hold the function of diagnostic imaging domain. In addition, 
in the case of drug delivery and release, iron oxide core or gold NPs/nanoshells also 
can act as a stimulus source to release therapeutic payload. 
1.3 Magnetic materials and iron oxide nanoparticles 
1.3.1 Magnetic materials 
Magnetism is a class of physical phenomena that are mediated by magnetic fields. 
Electric currents and the magnetic moments of elementary particles give rise to a 
magnetic field, which acts on other currents and magnetic moments. 
When applying a magnetic field to materials, the materials will interact with the 
magnetic field and their magnetic properties are characterized by the magnetization M 
(the magnetic moment per volume). A plot of the magnetization against the field 
strength is called a magnetization curve. 
The magnetization depends on the magnetic field strength (H) and the nature of each 
material [60]. This is expressed by Eq. 1.1: 
M = χH   (Eq.1.1) 
(χ is the susceptibility of the material) 
Based on the sign and the size of χ, magnetism can be classified as follows: 
- Diamagnetism (χ negative, small) 
- Paramagnetism (χ positive, small) 
- Ferromagnetism(χ positive, large) 
- Antiferromagnetism (χ positive, rather small) 
- Ferrimagnetism (χ positive, rather large) 
Diamagnetism: Materials can have or not have intrinsic electron magnetic moments, 
depending on the electron state of materials. In case the materials do not have electron 
magnetic moments (all electrons are paired), magnetic dipoles will be formed that 
oppose the applied magnetic field. Magnetism here is diamagnetic, and χ is negative 
and small (see Fig. 1.9). [61] 
Paramagnetism: In a paramagnet, there are unpaired electrons in atomic or molecular 
orbitals. These unpaired electrons are free to align their magnetic moment in any 
direction. When an external magnetic field is applied, these magnetic moments will 
tend to weakly align themselves in the same direction as the applied field. Therefore, χ 
is positive and small. 
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Ferromagnetism: A ferromagnet, like a paramagnet, has unpaired electrons. 
However, the intrinsic electron magnetic moments have a tendency to be parallel to 
an applied field and be parallel to each other to maintain a lowered-energy state (see 
Fig. 1.9). Thus, even in the absence of an applied field, the magnetic moments of the 
electrons in the material spontaneously line up parallel to one another. In this case, χ is 
positive and large.  
Every ferromagnetic substance has its own individual temperature, called the Curie 
temperature, above which it loses its ferromagnetic properties and becomes a 
paramagnet. This is because the thermal tendency to disorder destroys the 
ferromagnetic order. Ferromagnetism only occurs in a few substances; the common 
ones are iron, nickel, cobalt, their alloys, and some alloys of rare earth metals. 
 
Fig. 1.9: Visualization of magnetic orderings and their magnetization responses 
(M) as a function of applied magnetic field strength (H). Note that for ferro- and 
ferri-magnetism, materials are assumed to be magnetized first. Adapted with 
permission from Ref. [61]. 
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Magnetic domain: The magnetic moments in a ferromagnetic material are localized in 
small regions called magnetic domains (Weiss domain) (see Fig. 1.9). In each domain, 
magnetic moments stick together and align themselves in the same direction. When 
exposed to a magnetic field, the domain boundaries move so that the domains align 
parallel with the magnetic field and dominate the structure. When the external 
magnetic field is removed, the domains still remain in their positions. So, the 
ferromagnetic material is magnetized and becomes a permanent magnet.  
Antiferromagnetism: In an antiferromagnet, unlike a ferromagnet, there is a tendency 
for the intrinsic magnetic moments of neighboring valence electrons to point 
in opposite directions. Antiferromagnets have a zero net magnetic moment, meaning 
no field is produced by them. Antiferromagnets are less common compared to the 
other types of magnetism, and are mostly observed at low temperatures. 
Ferrimagnetism: Like antiferromagnets, neighboring pairs of electron spins like to 
point in opposite directions. However, these magnetic moments do not cancel 
completely (see Fig. 1.9). Therefore, a ferromagnetic material still retains its 
magnetization in the absence of a magnetic field, like a ferromagnetic material. 
Most ferrites are ferrimagnetic materials. The first discovered magnetic 
substance, magnetite, is a ferrite and was originally believed to be a ferromagnet. 
Superparamagnetism: When the size of a ferromagnet or ferrimagnet is sufficiently 
small (smaller than single domain size), it exits as a single domain and acts like a 
single magnetic spin that is subject to Brownian motion. Magnetic moments can orient 
freely in all possible directions, resulting in a non-magnetized state of the material. 
When an external magnetic field is applied, the magnetic moments in all single 
domains align to the magnetic field. These properties are similar to those of a 
paramagnetic magnetism, and the material will return to the non-magnetized state 
when removing the external magnetic field. This kind of material is called a 
superparamagnetic material.  
The estimated single domain size for spherical magnetite particles is 128 nm [62] 
whereas Fe3O4 NPs below 25 nm can exhibit characteristics of superparamagnetic NPs 
[63]. 
In general, to obtain a material with large magnetic susceptibilities, atoms with large 
magnetic moments (e.g., Fe, Ni, Co) need to be incorporated. We choose IONPs for 
our study due to several reasons. Firstly, Iron oxide (magnetite, maghemite) has large 
magnetic moments. Secondly, there are several rapid and economical methods 
allowing to prepare IONPs in large quantities. Thirdly, IONPs themselves show low 
toxicity, biocompatible, which is important for applications in biomedical field. And 
lastly, properties of IONPs including structural, chemical and physical properties are 
available in the literature [5], [64]–[68].  
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1.3.2 The iron oxides 
IONPs can have different morphologies, such as hematite (α-Fe2O3), maghemite (γ-
Fe2O3) or magnetite (Fe3O4).  
Maghemite and Magnetite are ferrimagnetic materials whereas hematite is an 
antiferromagnetic material. So, we only describe the first two magnetic types of iron 
oxide. A summary of practical data on iron oxides is shown in Table 1.3 [69]. 
Magnetite, Fe
2+
(Fe2
3+
O4), has a black color. It is a member of the cubic ferrites, also 
called ferrospinels because their structure is closely related to that of the mineral 
spinel, MgO·Al2O3 [70], [71]. In the spinel structure, the larger oxygen ions are 
packed quite close together in a face-centered cubic arrangement and the much smaller 
metal ions occupy the spaces between them. There are two kinds of spaces available, 
tetrahedral A sites and octahedral B sites (see Fig. 1.10). In the normal spinel structure 
(e.g., MgO·Al2O3), all Al
3+
 ions are located in octahedral B sites, and all Mg
2+
 ions are 
located in tetrahedral A sites.  
Magnetite exhibits an inverse spinel structure. Half of the Fe
3+
 ions are located in the 
tetrahedral and a half of the Fe
3+
 are located in the octahedral lattice sites, while Fe
2+
 is 
only in the octahedral sites [72]. This arrangement causes the magnetic moments of 
Fe
3+
 to cancel each other out (tetrahedral and octahedral sites have opposite spins), 
leaving only the moment of Fe
2+
 contributing to the overall magnetic moment (see Fig. 
1.11). As mentioned above, magnetite is a ferrimagnetic material. 
Maghemite (γ-Fe2O3) has a dark brown color and a similar crystal structure as 
magnetite. The difference is that there are vacancies in the cation sublattice and the 
result can be called a defect spinel.  
Table 1.3: Practical data on iron oxides [69].  
Structure Magnetite 
Fe3O4 
Maghemite 
γ-Fe2O3 
Hematite 
α-Fe2O3 
Structural type Inverse spinel Defect spinel Corundum 
Crystallographic system Cubic Cubic Hexagonal 
Ms at 300 K (emu/g) 92-100 60-80 0.3 
Curie temperature (K) 850 820-986 956 
Density (g/cm
3
) 5.15 4.9 5.3 
Percentage iron (%) 72.4 69.94 69.94 
Color in dispersion Black Dark brown Blackish red 
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1.3.3 Synthesis method 
Many studies on the synthesis of Fe3O4 nanoparticles have been reported so far [62], 
[63], [65], [73], [74]. The first and most widely used method is co-precipitation. Other 
methods include the polyol and thermal hydrolysis method, micro-emulsions, thermal 
decomposition, laser ablation, flow-injection. The properties of the most common 
methods are compared in Table 1.4 [62], [63], [65], [73], [74].  
Although thermal decomposition occurs at high temperature, the procedure does not 
require any special equipment. This method also allows to achieve large quantities of 
the product with high quality. Therefore, IONPs were mainly synthesized by this 
method in this dissertation.  
 
Fig. 1.10: AB2O4 spinel structure. Reprinted with permission from Ref. [71] 
 
 
Fig. 1.11: Arrangement of magnetic moments in magnetite crystal and hematite 
crystal.  
 
 A) Magnetite 
Tetrahedral sites 
A 
 
Octahedral sties 
B 
B) Hematite 
Octahedral sties 
 
 
Octahedral sties 
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Thermal decomposition 
The decomposition of iron precursors in the presence of hot organic surfactants results 
in samples with good size control, narrow size distribution and good crystallinity. 
Moreover, the obtained IONPs are well dispersed in the organic phase due to the 
presence of a coating layer. Initially, this method was used for the synthesis of 
semiconductor NPs. Later, the method was adapted for the synthesis of IONPs. 
Different organometallic precursors, solvents and surfactants can be used for the 
synthesis. However, the change of each of the above factors, together with reaction 
temperature and aging time, will result in a change of shape, size and magnetic 
properties of the obtained IONPs. Possible iron precursors are the complexes of 
acetylacetonate (acac), carbonyl, oleic acid/fatty acids, N-nitrosophenylhydroxylamine 
(cup). [62], [75]–[78].   
Among the iron precursors mentioned above, iron oleate is the most inexpensive one 
and can be easily prepared from iron (III) chloride and sodium oleate. Another 
advantage is the nontoxicity of all reactants. Park et al. were able to synthesize up to 
40 g of monodisperse IONPs in a single reaction batch [79].  
Although the mechanism of the reaction is not fully described [80], the observation of 
some side products such as radicals and ketones give some hints for the mechanism. 
The most complete description has been published by Perez et al. [81]. Fig. 1.12 
describes the mechanism with the formation of a radical under heating at the start. This 
step plays an important role because it provides the oxygen for the iron oxide 
Table 1.4: Common methods for the fabrication of Fe3O4 NPs. Thermal 
decomposition method was preferred because it can produce high quality product 
(narrow size, good shape control) at the large scale. Adapted with permission from 
Ref. [15]. 
Method 
co-
precipitation 
microemulsion hydrothermal 
thermal 
decomposition 
Conditions air air high pressure air/inert gas 
T (
o
C) 20-95 20-50 180-220 180-350 
Solvent water water in oil 
water-
alcohols 
long 
hydrocarbons 
Distribution broad medium narrow very narrow 
Size 2-100 1-50 10-800 3-50 
Shape 
control 
not good good good good 
Scale (gram) 
large 
(0.1-2) 
small 
(0.1-0.3) 
small 
(0.1-0.5) 
large 
(1-40) 
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formation as well as the reduction of Fe
3+
 to Fe
2+
. The observation of ketones at 
different stages in the reactions is explained by the combination of two radicals. 
A drawback of this method is the low saturation magnetization of IONPs - typically 25 
emu/g [75] whereas the value of bulk Fe3O4 is 92-100 emu/g [69] – which can be 
partly explained by the small size of the obtained particles.  
Besides thermal decomposition, another method - called forced hydrolysis - is used to 
synthesize IONPs in this dissertation (only in Chapter 2). Basically, this method is a 
modification of the polyol and hydrothermal reactions [65], [82]. The technique is 
based on the dissolution of iron salts in a polyol solvent with subsequent heating or 
reflux in the present of a capping agent. Typical synthesis can lead to a yield of 1 gram 
of NPs with high magnetization [63]. The experimental route will be described briefly 
in Chapter 2. 
  After synthesis, obtained IONPs are coated with oleic acid. The particles are only 
dispersible in apolar solvents (e.g., hexane, chloroform). For further use in biomedical 
applications, the surface needs to be functionalized with a polar moiety. The surface 
functionalization does not only provide a functional group, but also improves the 
 
Fig. 1.12: The decomposition of iron-oleate at high temperature happens via a 
radical process. Carbon dioxide gas is released from the oleate molecules in one of 
these reaction steps. Adapted with permission from Ref. [15]. 
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stability of the colloidal IONPs. The following section will give an overview of the 
different functionalization strategies.  
1.3.4 Surface functionalization of IONPs 
IONPs are coated with protecting agents in order to improve the chemical or physical 
stability, as well as to provide functional groups for their applications [83]–[85]. 
Surface coating protects the NP from the environment and sustains the properties of 
the core. The improvement of the physical stability should be understood as the 
prevention of aggregation from colloidal dispersion - which will be discussed in the 
next section.  
There are three strategies to functionalize IONP’s surface: using i) organic molecules, 
ii) polymers or iii) inorganic shell as described in Fig. 1.13. Some detailed discussions 
about the surface functionalization of IONPs can be found in the literature [15], [65].  
In iron oxide, the surface iron atoms act as Lewis acids and coordinate with molecules 
that donate lone-pair electrons. Therefore, interactions between IONPs and coating 
agents usually start with acid-base reactions. This can be easily seen in the case of 
functionalization by organic molecules, such as carboxylates (e.g., citric acid [86], 
dimercaptosuccinic acid (DMSA) [87], [88]) , phosphates [89]–[91], sulfates [62], 
derived catechol [92]–[94] and alkoxysilane [75], [95]. Another strategy is the use of 
polymers such as PEG, dextran, polyvinyl alcohol (PVA). IONPs are embedded in the 
matrix in which the interaction between iron atoms and oxygen atoms play an 
important role. 
IONPs can be coated with silica/mesoporous silica (mp-SiO2) [52], [96]–[99] or gold 
[100]–[102]. These coatings help in binding various biological ligands to the 
nanoparticle surface. An overview and experimental routes of the coating of IONPs by 
gold nanoshells will be discussed in detail in Chapter 3. Here, we only discuss the 
functionalization of IONPs with a SiO2/mp-SiO2 shell. The most popular method used 
to grow a silica shell is the Stöber method based on the hydrolysis and condensation of 
a silica precursor such as TEOS/EtOH in the presence of a base (NH3, NaOH,…) 
[103]. The Stöber method is known as an effective method to synthesize silica NPs, 
and its modification can lead to the formation of silica nanoshells. In addition, during 
the growth of the silica shell, a large excess of surfactants (e.g., 
cetyltrimethylammonium bromide/chloride [7], [104], [105]) can be added to form 
mp-SiO2 shells. Fig. 1.14 shows the pore system of mp-SiO2 taken by transmission 
electron microscopy (TEM) and scanning electron microscopy (SEM) [106]. 
Mesoporous silica is a mesoporous form of silica and a recent development 
in nanotechnology. The most common types of mesoporous nanoparticles are MCM-
41 and SBA-15 with a large pore size up to 30 nm [107], [108]. These pores are much 
larger than pores in microporous material. Research continues on the NPs/nanoshells, 
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Fig. 1.13: Overview of surface functionalization of IONPs by polymers, organic 
molecules or inorganic shells. Reprinted with permission from Ref. [15]. 
 
 
 
 
Fig. 1.14: SEM (a) and TEM (b) images of mesoporous silica nanoparticles. The 
insert image is a high-resolution electron microscopy image of a single silica 
particle. Reprinted with permission from Ref. [106]. 
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which have applications in catalysis, drug delivery and imaging [109]. The large 
surface area of the pores allows the particles to be filled with a drug or a cytotoxin. 
Ordered mesoporous silica  [106], [110]–[112] also shows potential to boost the in 
vitro and in vivo dissolution of poorly water-soluble drugs, such as itraconazole [113], 
[114].   
1.3.5 Colloidal stability 
The stabilization of IONPs in aqueous media is crucial for all advanced applications. 
The stability of a magnetic colloidal suspension depends on the relation between 
attractive and repulsive forces. There are four types of attractive/repulsive forces that 
are able to contribute to the interparticle potential in the colloidal system, including 
van der Waals forces, the electrostatic repulsive forces, magnetic dipolar forces and 
the steric repulsions. To be stable, colloidal NPs need to have repulsive forces that are 
more dominant than the attractive forces. This can be achieved by altering the 
electrostatic and steric forces (see Fig. 1.15). The steric force is very important when 
the particles are coated with a polymer [115]. In many cases, it plays a key role for the 
stability of the colloidal system [75]. The steric force depends on the molecular weight 
of the polymer and its density [116], [117]. The electrostatic repulsion can be 
estimated through the zeta potential (ZP) measurement  [15], [118]. In the absence of 
steric stabilizers, the system is admitted as colloidal stable if the absolute value of the 
ZP is higher than 25 mV [15], [119]. However, a colloidal suspension with a low ZP 
value can still be highly stable if steric stabilizers are present [75].  
 
Fig. 1.15: (a) Particles stabilized by the electrostatic layer. (b) Particles stabilized 
by steric repulsion. Reprinted with permission from Ref [65]. 
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 1.4 Plasmonic properties  
1.4.1 Interaction of metals with light – the Surface Plasmon 
Resonance 
It is generally known that all interesting properties of metals are due to the presence of 
valence electrons. When light interacts with the metal, the electromagnetic field of 
light causes the electrons to move with respect to the positive cores, leading to the 
formation of a dipole oscillation (see Fig. 1.16). When the amplitude of this oscillation 
reaches a maximum at a certain wavelength, the oscillation is called a (localized) 
surface plasmon resonance (LSPR) [120]–[124].  
The resonant frequency (or wavelength) plays an important role. If the frequency of 
the incident light is greater than the resonance frequency of the metal, light will be 
transmitted. Otherwise, light is reflected. Because most metals have a resonance in the 
UV region, visible light will be reflected by these metals. This explains the shiny 
surface of most metals. On the other hand, gold and copper have an optical resonance 
frequency in the visible region. This results in their distinct color.  
Because the LSPR induces a strong absorption of the incoming light, the absorption 
can be recorded by using a UV–Vis spectrometer. Gold NPs (together with silver and 
copper NPs) exhibit a strong LSPR band in the visible region, while other metallic NPs 
exhibit a broad and weak band in the UV region [125], [126]. For example, Au NPs 
show an SPR band around 520 nm.  
The SPR band is affected by the particle shape and size [120], [121], [127], hence Au 
NPs with different shape and size exhibit different colors and their colors differ from 
the color of bulk gold. Fig. 1.17 shows the color of bulk gold (left) and colloids of gold 
nanoparticles in a Gothic stained glass rose window of Notre-Dame de Paris (right) 
[128].  
 
Figure 1.16: Schematic illustration of surface plasmon resonance in plasmonic 
nanoparticles, where E is the electric field and K is the wave vector (the direction 
of the light propagation). Reprinted with permission from Ref. [121]. 
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The position and intensity of the LSPR band is determined by the electron density on 
the surface of the metal. Hence, metal type, particle shape (nanosphere, nanorod…), 
size, structure (metallic NPs, metallic shells….) and the dielectric constant of the 
medium all affect the position of the plasmon band. All these factors can be described 
theoretically by Mie theory [121], [122], [129], [130]. The following section will 
discuss the effect of these parameters on the position of LSPR bands.  
Another interesting property of LSPR comes from the enhancement of the amplitude 
of the field near metal surface. This field is highly localized at the metal surface 
(within 10 nm from the interface) and decays rapidly. So, any molecule present within 
this distance from the NP surface will experience these large fields [120][131]. This 
leads to several interesting applications in “surface-enhanced’’ spectroscopies, 
including surface-enhanced Raman spectroscopy (SERS) [124], [132]. 
1.4.2 Position of the SPR band of Au NPs 
Intensity and position of the SPR band can be predicted from Mie theory – which is 
the Mie solution to Maxwell’s equation for the interaction of an electromagnetic plane 
wave with a nanoparticle. Different geometry of Au nanoparticles leads to different 
solutions. In the simplest case, spherical Au NPs, the extinction cross-section (Cext) is 
determined by the following equation [121][129]:  
𝐶𝑒𝑥𝑡 =  
24𝜋2𝑅3𝜖𝑚
3/2
𝜆
𝜖2
(𝜖1+2𝜖𝑚)
2+ 𝜖2
2  (Eq. 1.2) 
   
Figure 1.17: (left) color of bulk gold and (right) color of colloids of Au NPs in a 
Gothic stained glass rose window of Notre-Dame de Paris [128] 
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Where:  R is the radius of Au nanospheres,  
𝜖𝑚 is the dielectric constant of medium, 
𝜖 = 𝜖1(𝜔) + 𝑖𝜖2(𝜔) is the dielectric constant of the metal. 
Note that Eq. 1.2 is only valid when the size of Au NPs is much smaller than the 
wavelength of incident light and only dipole oscillator contributes to the extinction 
cross-section.  
When Cext is maximum, 𝜆 = 𝜆𝑝𝑒𝑎𝑘. This happens when: 
 𝜖1 + 2𝜖𝑚 = 0  (Eq. 1.3)   or   𝜖1 = −2𝜖𝑚   (Eq. 1.4) 
On the other hand, the position of SPR peak (𝜆𝑝𝑒𝑎𝑘) is determined from following 
equation [130]: 
𝜆𝑝𝑒𝑎𝑘
2
𝜆𝑝
2 =  𝜖
∞ + 2𝜖𝑚  (Eq. 1.5) 
Where:   𝜆𝑝 is the bulk metal plasmon wavelength,  
  𝜖∞ is the dielectric constant of the bulk metal at infinitive wavelength. 
Using Eq. (1.2) and Eq. (1.5), one can predict the change of LSP band when 
parameters such as particle size (R) and refractive index of the medium (n) change. 
(𝑛 = √𝜖𝑜. 𝜇 where: µ is the relative permeability of the medium and 𝜖𝑜 is the vacuum 
dielectric constant of the medium) 
In following paragraphs, experimental data will be discussed to confirm the prediction 
from Mie theory.  
As mentioned above, the position of the SPR band of Au NPs firstly depends on the 
size of the NPs. E.g., spherical Au NPs show a SPR band around 520 nm whereas that 
of Au NPs smaller than 10 nm is largely damped. This is explained by the surface 
scattering of the conduction electrons [130] and by the phase change of Au NPs caused 
by the increased rate of electron-surface collisions compared to larger particles [121]. 
Some studies reported that 4 nm Au NPs still exhibit a weak SPR band at around 515 
nm [120], however Au NPs smaller than 2 nm does not exhibit the SPR [133]. On the 
other hand, increasing particle size red-shifts the SPR wavelength and also increases 
the intensity (see Fig. 1.18a). 
Secondly, the position of SPR bands depends on the shape of NPs (e.g., nanospheres 
[121], nanorods [120], [134], nanocages [135], nanorices [136]). Fig. 1.18b illustrates 
the optical properties of gold nanoparticles that change drastically with nanoparticle 
shape. The photograph shows an aqueous solution of 4 nm gold nanospheres (vial 0) 
and gold nanorods (1-5) with progressively higher aspect ratio. The optical spectra for 
the particles in vials 1–5 are also shown.  
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Thirdly, the position of the band depends on the colloidal stability of Au NPs. 
Aggregation of noble metal nanoparticles red-shifts and broadens plasmon bands. For 
colloidal 4 nm Au nanospheres, this results in a visual color change from orange–red 
to purple or blue (see Fig. 1.19). The aggregation depicted here resulted from an 
increased ionic strength in aqueous solution. Finally, the position also depends on the 
 
Fig. 1.18: The optical properties of gold nanoparticles change drastically with 
nanoparticle size (a) and shape (b). (a) SPR band of Au nanospheres is red-shifted 
when size increase, reprinted from Ref. [198]. At 150 nm, Au nanospheres exhibit 
two SPR bands corresponding to transversal and longitudinal SPRs (Au NPs are 
not completely spherical due to defects in their nanostructures). (b) The 
photograph shows aqueous solution of 4 nm gold nanospheres (vial 0) and 
progressively higher aspect ratio gold nanorods (1–5). Reprinted with permission 
from Ref. [120]. 
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medium surrounding Au NPs, represented by the refractive index. Increasing the 
refractive index of the medium for Au NPs red-shifts the LSPR wavelength and 
strongly enhances the intensity of the resonance [61], pp. 24. 
1.4.3 Position of the SPR band of Au nanoshells.  
The combination of a magnetic iron oxide core and a plasmonic gold shell in a single 
nanostructure results in many interesting properties.  The addition of a gold coating 
layer can be exploited in many advanced applications such as recoverable catalysts, 
bio-separation, diagnostics, photon-induced hyperthermia. The synthesis of iron oxide-
gold core-shell NPs will be discussed in detail in Chapter 3. Here, we only discuss 
factors affecting the position of the SPR band of Au nanoshells.   
Following Mie theory [122],  the position depends firstly on the composition of the 
core. Different materials of the core with different permittivity can result in different 
positions of the SPR band. Secondly, the band depends on the core/shell ratio. On the 
other hand, with a given core, the position changes when the thickness of the Au shell 
changes. Following Levin et al., if the permittivity of the core is low (e.g., silica), the 
SPR band will blue-shift when the shell thickness increases. Otherwise, if the 
permittivity of the core is high (e.g., iron oxide), the band will red-shift to the NIR 
region when the shell thickness increases [101].  
Note that when Au shell is thick enough, valence electrons on the surface of outer shell 
and inner shell are isolated, resulting in two different surface plasmonic resonances 
(see Fig. 1.20 and Fig. 1.21).  
Fig. 1.20a describes the optical properties of a core-shell nanostructure consisting of 
60 nm silica core and a gold shell. Shell thickness can vary from 5-20 nm. The 
 
Fig. 1.19: Aggregation of 4 nm Au nanospheres induces the red-shift and the 
broadening of SPR band. This results in a visual color change from orange–red to 
purple or blue. Reprinted with permission from Ref. [120]. 
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Fig. 1.20: Tunable optical properties of gold-coated 60 nm silica core by changing 
the shell thickness (5-20 nm). (a) Theoretical calculation of SPR bands, reprinted 
with permission from Ref. [195]. Practical absorption spectra (b) and physical 
appearance (c) of Au nanoshells with thickness varying from 5-20 nm. Reprinted 
with permission from Ref. [121].  
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position of the SPR bands were theoretically calculated, showing a blue shift when the 
shell thickness increases. The experimental data in Fig. 1.20b,c also agree with the 
calculation.  
Another example is the observation of gold nanoshell growth on the surface of 120 nm 
silica cores (see Fig. 1.21). Gold is gradually deposited on the silica surface, leading to 
the formation of incomplete Au nanoshells and then complete Au nanoshells. Their 
TEM images are shown in Fig. 1.21a-f whereas the absorption spectra of incomplete 
and complete gold shells are shown in Fig. 1.21g.  The SPR bands tend to red-shift 
when the shell is incomplete and blue-shift when the shell is complete. 
1.5 Nonlinear optics 
When light with frequency ω interacts with a molecule, its oscillating electric field will 
induce a dipole moment in the molecule. In general, the induced dipole moment µ(ω) 
can be described as a Taylor series [137]: 
 
Fig. 1.21: (a – f) TEM images of nanoshell growth on 120 nm silica NPs. (a) Initial 
gold colloid-decorated silica nanoparticle, (b – e) gradual growth and coalescence of 
gold colloid on silica nanoparticle surface, (f) completed growth of metallic nanoshell. 
(g) UV-Vis spectra of colloidal dispersion during nanoshell growth indicate that the 
SPR bands tend to red-shift when the shell is incomplete and blue-shift when the shell 
is complete. Reprinted with permission from Ref. [195] 
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µind = µ(1) + µ(2) + µ(3) + …. = αE + βEE + γEEE (Eq. 1.2) 
Where: µ
(1)
, µ
(2)
 and µ
(3)
 is linear, quadratic and cubic, respectively, in the electric 
field. α(ω) is the molecular first-order polarizability or linear polarizability. β(ω) and 
γ(ω) are the molecular second-order and third-order nonlinear polarizabilities. They 
are also called the first and the second hyperpolarizability. Since the induced dipole 
moment can be considered as the source of radiation, Eq. 1.2 can be used to describe 
all molecular optical properties.  
However, when the intensity of the light is sufficiently low,  µ
(2)
 and µ
(3)
 are very small 
and the induced dipole moment can be approximated as being linear in the electric 
field.  
µind  = µ
(1)
 = α(ω)E(ω)  (Eq. 1.3) 
In principle, this equation is sufficient to describe daily optical phenomena such as 
light scattering, absorption, etc. 
At the macroscopic level, we consider the interaction of light with many molecules. In 
this case, we define the induced polarization of the entire medium as: 
Pind = P
(1)
 + P
(2)
 + P
(3)
 + …. = χ
(1)
E + χ
(2)
EE + χ
(3)
EEE (Eq. 1.4) 
Where χ
(1)
, 
 
χ
(2)
 and χ
(3)
 are the first-, second- and third-order susceptibilities of the 
sample( also called the first and second nonlinear susceptibilities).  
Both hyperpolarizabilities and susceptibilities are used to describe nonlinear optical 
phenomena that only occur at very strong light intensities (for example laser light).  
Well-known nonlinear optical phenomena are second-harmonic generation (SHG), 
hyper-Rayleigh scattering (HRS), two-photon fluorescence (2-PF), Third-harmonic 
generation (THG) and third-harmonic scattering (THS). 
All of them are processes in which two or three photons are annihilated to create a new 
photon at a different frequency.  
The interaction of the matter with two photons (SHG, HRS, 2-PF) or three photons 
(TGS, THS) can be visualized by the energy diagrams in Fig. 1.22. Note also that SHG 
(and HRS) and THG (and THS) can be non-resonant, while TPF has to be resonant in 
order to occur.  
Whether or not a molecule or material exhibits strong nonlinear optical properties 
depends on several factors. However, an important one is symmetry of the medium 
under investigation. SHG and HRS only occur when the material or molecule is 
noncentrosymmetric, while THG, THS and 2-PF can occur in any material. 
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1.6 Objective and outline 
The aim of this dissertation is to design versatile MuNPs based on IONPs and explore 
some potential applications of these materials in biomedical field. To be used in 
biomedical applications, the particles must be biocompatible and dispersable in water. 
Moreover, different properties need to be combined in one single particle for different 
purposes. Firstly, the particles gain interesting magnetic properties from iron oxide 
core, which can be exploited in bioseparations, MRI and magnetically induced 
hyperthermia. Besides, the particles might possess plasmonic properties for SPR-based 
biosensing and laser-induced hyperthermia, mesoporous silica shells for drug storage 
and delivery, or be conjugated to a fluorescent dye for imaging technique.  
In order to achieve the aim stated above, we discuss first the synthesis of different 
core-shell structures of MuNPs. The nanostructure composes of a well-defined iron 
oxide core and a mono/multi-layer(s) nanoshell. The latter provides the colloidal 
stability, biocompatibility and more extra interesting properties. Next, we characterize 
the linear and nonlinear optical properties, as well as magnetic, plasmonic and 
mesoporous properties of synthesized materials. Finally, we explore several 
 
Fig. 1.22: The energy diagrams involve to multiphoton processes. In diagrams (a) 
and (c), matter interacts with two photons (a) or three photons (c) to form a virtual 
excited state (dashed lines), which is extremely short-lived. This leads to the 
emission of a photon with double or triple frequency. Energy diagram (b) refers to 
2-photon fluorescence phenomenon in which matter absorbs two photons to reach 
its excited state (solid line). During the process, a part of the energy is lost and a 
photon (ω’ < 2ω) light is released. 
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applications of the MuNPs in some biomedical field, including protein coupling, 
nonlinear imaging, magnetically controlled drug release. 
The outline of this dissertation is as follows: 
The second and the third chapters focus on the functionalization of IONPs. In Chapter 
2, IONPs are synthesized and are functionalized with carboxyl-terminated 
trialkoxysilane. Then, the ability of carboxyl functionalized IONPs to couple with bio-
entities are tested with bovine serum albumin protein. The amount of protein coupling 
is quantified by the Bradford method.   
Chapter 3 gives an overview of the synthesis of water-soluble iron oxide-gold core-
shell NPs with different approaches. Gold nanoshells can be synthesized in an aqueous 
solvent or in an organic solvent. The syntheses of iron oxide-silica-gold and iron 
oxide-gold-silica multilayer nanoshells are also introduced in this chapter.  
The next two last chapters focus on the applications of synthesized core-shell NPs. 
Chapter 4 describes the design of rhodamine B bound iron oxide-mesoporous silica 
core-shell NPs as drug delivery agents. The hyperthermia-induced release of the 
payload is investigated under different magnetic fields.  
Finally, nonlinear optical properties of iron oxide-mesoporous silica core-shell NPs are 
studied in Chapter 5. The possibility to exploit the system as nonlinear 
imaging/labeling is also discussed there.  
 35 
Chapter 2 
Synthesis of functional magnetic 
nanoparticles for protein coupling  
 
 
 
 
 
 
 
Author performed all experiments, measurements and analysis in this chapter.
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Abstract 
Superparamagnetic iron oxide nanoparticles (IONPs) were synthesized and their 
surface was carboxyl functionalized with COOH- terminated PEG-silane. Then, these 
magnetic nanoparticles were used as agents to bind bovine serum albumin (BSA) 
protein and the coupling was studied by Bradford assay. Generally, about 20 µg of 
protein could be bound to 1 mg of magnetic nanoparticles. 
2.1 Introduction 
In recent years, nano-sized magnetic particles have received considerable attention 
from researchers in the field of medicine and biotechnology [138]. Magnetic particles 
have been widely studied and used in many applications such as immobilization of 
enzymes [139], immunoassays [140], bioseparation [141], biosensor
 
[142], targeting 
drugs [11][143], MRI reagents [144] and cancer hyperthermia treatment [145], [146]. 
These biomedical applications are due to the fact that tiny particles can penetrate the 
body without a specific reaction with antigens. Among magnetic materials, magnetite 
NPs are the most frequently chosen for the above studies, because these particles can 
be easily synthesized on a large scale and their magnetization is quite high allowing 
control by an external magnetic field.  
Biomedical applications require magnetic nanoparticles (MNP) to be capped and 
surface functionalized. With the help of silane chemistry, a stable coating layer can be 
easily formed on the MNP surface and can provide many kinds of functional groups 
such as carboxyl, amine, hydroxyl, …[63], [147]–[149]. These functional groups are 
the basis for MNPs to make the coupling with many bioactive substances such as 
antibodies, enzymes. Owing to their magnetic properties, using protein - MNP 
conjugations is a promising approach for many bio-applications such as diagnostics 
and drug targeting. 
For applications in bioseparation, IONPs perform as excellent materials. IONPs with 
different coating layers were used to separate target ions, molecules, cells or bacteria 
from aqueous solution [50], [150], [151]. The nanoparticles need to meet the following 
requirements: i) high colloidal stability, ii) high magnetic response and iii) high 
selectivity toward target. While all these criteria are important, the last one is the most 
difficult to achieve. Some studies report the utilization of IONP-antibody conjugate for 
bioseparation due to specific interactions between antibody and target. Recently, 
Bloemen et al. functionalized IONPs with customized PEG ligands and then with 
antibody for the selective separation of Legionella pneumophila bacteria [50]. The 
conjugate is hydrophilic and the antibody remains active to bacteria. However, the 
magnetization of IONPs should be improved to expand their potential applications in 
bioseparation. 
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In this chapter, we focus on a facile synthesis of carboxyl functionalized magnetite 
NPs with high colloidal stability and extremely high magnetic response and focus on 
the coupling of functional MNPs to BSA protein. The experiments described in this 
chapter lay a foundation for future functionalization of IONPs with targeting agents 
such as antibodies.  
IONPs were synthesized by the forced hydrolysis method, and then carboxyl 
functionalized based on a silanization method. The advantages are: trialkoxysilanes 
can provide a more stable coating via covalent bonds and the IONP surface could be 
modified with a wide range of functional groups by applying various substituted 
silanes [63], [147]–[149]. A mixture of PEG-silane and COOH-silane (Fig. 2.1) was 
used as a coating reagent for the silanization. While PEG-silane was necessary to form 
a stable coating layer and increase the ability of the particles to disperse in many 
solvents, COOH-silane would provide carboxyl functionalized groups on the surface 
of IONPs. Functionalized IONPs could be covalently coupled with BSA protein via an 
amide bond [14], [50]. The reaction takes place between carboxylic groups on the 
magnetic particles surface and amine groups in BSA in the presence of activating 
substances: 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 
hydroxysuccinimide (NHS) [152]. The reaction is illustrated in Fig. 2.2. 
There are several methods to determine the amount of protein coupled to IONPs. In 
this study, we used Bradford assay, one of the most common assays for protein 
quantification because of its rapid and sensitive characteristics [153], [154] (see 
Section 2.5, SI). The principle of this method relies on the strong attraction (1:1 ratio) 
  
Fig. 2.1: The structures of PEG-silane (a) and COOH-silane (b).  
(a) methoxy(polyethyleneoxy)propyltrimethoxysilane (9-12 PE-units)  
(b) (Trimethoxysilylpropyl)ethylenediaminetriacetic acid trisodium salt. 
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between protein and Bradford reagent (CBB-Coomassie Brilliant Blue G-250) which 
leads to an increase of the solution absorbance at 595 nm. The amount of protein 
present was determined by the amount of CBB bound to protein – which can be 
determined photometrically.  
 
 
Fig. 2.2: Mechanism of reaction between carboxylic and amine groups with the 
activation of EDC and NHS [152]. EDC reacts with a carboxyl group on molecule 
#1, forming an amine-reactive O-acylisourea intermediate. This intermediate may 
react with an amine group on molecule #2, forming a conjugate of the two 
molecules joined by a stable amide bond. However, the intermediate is very 
susceptible to hydrolysis (rate constant measured in seconds), making it unstable 
and short-lived in aqueous solutions. The addition of NHS stabilizes the amine-
reactive intermediate by converting it to an amine-reactive NHS ester, thus 
increasing the efficiency of EDC-mediated coupling reactions 1,2. The amine-
reactive NHS ester intermediate has sufficient stability to permit two-step cross-
linking procedures, which allows the carboxyl groups on one protein to remain 
unaltered. Besides, there are some side reactions of O-acylisourea ester, however 
these reactions do not affect to the main reactions because of the lack of activity. 
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2.2 Experimental section 
2.2.1 Synthesis of superparamagnetic IONPs  
n-Octylamine-coated IONPs were synthesized following a published protocol 
with minor modifications [63]. Details can be found in the SI. Briefly, Ferric 
chloride (FeCl3) is used as a salt precursor, ethylene glycol as both solvent and 
reductant. n-Octylamine functions as both a capping agent and a preliminary coating 
layer.  
2.2.2 Synthesis of carboxyl functionalized IONPs 
The functionalization of the IONP surface was performed by a silanization method 
described by Brullot et al.
 
with some modifications [63]. In detail, newly synthesized 
IONPs (100 mg of) were dispersed in 100 mL of toluene by sonicating for two hours. 
After that, 0.5 mL of two silanes (PEG-silane and COOH-silane) with different 
volume ratios was added sequentially to the suspension, followed by the addition of 
one drop of pure acetic acid. The functionalization can be facilitated by one of the two 
following methods: a) sonication for two hours or b) magnetic stirring for 24 hours. 
After the reaction, an sufficient amount of heptane was added to induce precipitation 
and functionalized IONPs were collected by a magnet. Finally, the particles were 
washed three times with acetone and dried in a vacuum for 30 minutes.  
A series of carboxyl functionalized IONPs was formed by varying the volume ratio of 
PEG-silane, from 10 % to 100 %, and samples were named by the percentage of 
COOH-silane used and the method (a or b) of synthesis. For instance, the C10a sample 
refers to IONPs coated by 10 % volume of COOH-silane (and 90 % volume of PEG-
silane) and prepared by functionalization method a. The sample C10b was used for 
further study of the coupling process later. 
2.2.3 Coupling functionalized magnetic nanoparticles to BSA 
protein 
For the preparation of all solutions in this experiment, 2-(N-morpholino)ethanesulfonic 
acid (MES) buffer solution (50 mM, pH=5.5) was used as a solvent. Typically, 3 mg 
of functionalized MNPs were dispersed in 1 mL of MES buffer solution. To this 
suspension, 50 μL of EDC/MES (20 mg/mL) and 50 μL of NHS/MES (20 mg/mL) 
were sequentially added. Notice that the EDC solution must be used immediately after 
the preparation. Next, the reactants were mixed by vortexing, followed by addition of 
40 μL of BSA protein MES (2.5mg/mL). Finally, the reaction mixture was mixed (by 
shaking or magnetic stirring) at room temperature for two hours. After reaction, the 
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protein-coupled magnetic particles were magnetically separated by using a magnetic 
separation (MS) column, washed with PBS buffer solution three times and then stored 
in 5 ml of PBS solution  at pH=7 (see Fig. 2.3).  
2.2.4 Quantification of protein binding to MNPs by Bradford’s 
method 
Preparation of protein sample: All protein samples needed to be dispersed in 50 mM 
pH 5.5 MES buffer solution before pouring into cuvettes. Next, the volumes were 
diluted up to 600 μL by MES buffer solution, followed by the addition of 900 μL of 
CBB reagent. The mixture was mixed and then incubated for 30-60 minutes at room 
temperature. The absorption of all samples was recorded in the range from 500-700 
nm with a reference cuvette containing 600 μL of MES and 900 μL of CBB. The 
increase at the wavelength of maximum absorption (normally 599 nm) was recorded. 
 
Fig. 2.3: Schematic overview of protein coupling and separation procedure. First, 
carboxyl-functionalized IONPs were covalently bound to protein via an amide 
bond in the presence of EDC and NHS. Then, the obtained solution was poured to 
a magnet-attached MS column. Nonreacted protein freely flowed through the MS 
column while protein-coupled IONPs were kept inside the column. Finally, these 
magnetic NPs were collected by the removal of the magnetic field followed by the 
addition of an appropriate solvent.  
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Calibration curve: Standard protein samples containing free protein were also 
prepared in the same way as described above. We measured calibration curves and the 
results are shown in Fig. 2.S3 and 2.S4, SI. 
Calculation of bound protein: After each coupling reaction between functional MNPs 
and BSA protein, protein bound MNPs were magnetically separated and dispersed in 5 
mL of MES buffer solution. On the other hand, all supernatant solutions were also 
collected and diluted to 5 mL by MES buffer solution. The amount of reacted protein 
was determined directly by using a pellet sample or indirectly by using the supernatant 
as described above.   
Due to the high sensitivity of Bradford’s method, each experiment was repeated 2-4 
times with different volumes of the sample (for instance: 150μL, 300μL, 450μL, 
600μL), after which the average amount of BSA was calculated. 
2.3 Results and discussion 
2.3.1 Characterization of synthesized n-octylamine-coated 
IONPs 
IONPs were synthesized based on forced hydrolysis [63].
 
XRD showed that the 
synthesized particles were composed of magnetite (Fe3O4) [63].
 
According to Brullot 
[69], DLS measurements of magnetite nanoparticles in toluene showed that the mean 
size of MNPs was 30 nm, resulting in a size of 27.2 nm of the magnetite core. A 
Fig. 2.4: TEM image of n-octylamine coated IONPs (left, scale bar 20nm) and a 
histogram of the size distribution (15.7 ± 2.4 nm) of n-octylamine coated IONPs 
(right). 
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magnetic measurement, performed by vibrating sample magnetometer (VSM), showed 
a saturation magnetization (Ms) of 35 emu/g at 5T and room temperature (Ms value of 
bulk Fe3O4 is 92-100 emu/g [69]). Fitting the magnetization curve to a Langevin 
function resulted in a magnetic core size of 8.9 nm [69]. Fig. 2.4 shows a TEM image 
of n-octylamine-coated IONPs with a size distribution of 15.7 ± 2.4 nm. The 
difference in size determined by the different techniques is due to several reasons. 
DLS yields a hydrodynamic diameter which will always be larger than the diameter 
determined by TEM. Furthermore aggregation of particles could be another reason for 
the larger diameter in DLS. The size determined from the Langevin function is smaller 
than the TEM size which is explained by the fact that the particle is assumed to be 
spherical and only consists of magnetite. However, a magnetite particle consists of a 
magneto-crystalline core and a disordered shell of spins (magnetically dead layer) 
[155] and the latter does not attribute to the magnetization of the particle. So, the 
diameter calculated from magnetization data is only the size of the crystalline 
magnetite core.  
Fig. 2.5 shows the structure of synthesized IONPs in which the surface of the particles 
is covered by a layer of n-octylamine due to the interaction between free -OH groups 
on the surface of IONPs and –NH2 groups. Owing to the coating, IONPs can be 
dispersed in solvents such as methanol, toluene. These rather weak bonds also enable 
the coating ligands to be exchanged in the silanization reaction later.  
The attachment of octylamine on the IONP surface was confirmed by investigating the 
infrared spectra of the coating (free octylamine) and the product (octylamine-coated 
magnetite particles). A FT-IR spectrometer equipped with a diamond ATR sample cell 
was used for all IR measurements in this study. These spectra are combined in Fig. 2.6, 
showing that the characteristic vibrations of octylamine all appear in the spectrum of 
 
Fig. 2.5: The possible structure of n-octylamine-coated magnetite nanoparticle. 
The interaction between –OH groups on the surface and –NH2 groups leads to the 
formation of the structure O
(-)
 H3N
+
R. 
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the product, for example the NH bend in primary amines. The absorption of the NH 
bend in the primary amines was shifted from 1601 cm
-1
 (spectrum a) to 1651 cm
-1
 
(spectrum b) due to the interaction with –OH groups on the surface. All main peaks of 
the functional groups were assigned and listed in Table 2.1.  
2.3.2 Characterization of carboxyl functionalized IONPs 
As mentioned in Section 2.2.2, the names of functional MNP samples are based on the 
percentage of the coating COOH-PEG used and the method of synthesis (a: ultrasonic 
method, b: stirring method). To investigate the effect of carboxylic groups on the 
stability and other properties of ferrofluids, C10a, C20a, C30a, C40a, C50a, C100a 
Table 2.1: Different vibration modes of the coating reagent (n-octylamine) and 
coated magnetite particles.  
 IR vibration modes (cm
-1
) 
n-Octylamine (free) 2955 (CH3 as), 2921 (CH2as), 2852 (CH2 s), 1601 (NH 
bend in primary amine), 1465 (CH2 bend), 1378 (CH3 
bend), 1072 (C-N) 795 (NH out of plane bending ), 722 
(long-chain band) 
n-Octylamine-coated 
Fe3O4  
(solid sample) 
3300-3000 (NH…), 2920 (CH2 as), 2849 (CH2 s), 1651 
(NH bend in primary amine), 1538 , 1454 (CH2 bend), 
1380 (CH3 bend), 543 (Fe-O) 
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Fig. 2.6: Formation of Fe3O4 NPs in the presence of octylamine as a capping 
reagent. Spectra show the characteristic vibrations of free octylamine (a) and n-
octylamine in the surface of the Fe3O4 surface (b). 
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samples were synthesized and characterized. In order to compare the efficiency of the 
two methods of synthesis, C10b and C100b samples were synthesized and their 
properties were compared to the properties of C10a and C100a samples. The properties   
of the functional MNPs were characterized by different techniques (IR spectroscopy, 
Dynamic Light Scattering, Zeta potential, Vibrating Sample Magnetometer). 
FT-IR spectroscopy: Firstly, surface modification of magnetite NPs was confirmed 
by FT-IR spectroscopy. Fig. 2.7 shows the infrared spectra of coating reagents and 
functional MNPs: C10a and C10b samples (solid pellets). Peaks were assigned and 
listed in the Table 2.2, and the main characteristic peaks of the coatings also appear in 
4000 3500 3000 2500 2000 1500 1000 500
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Fig. 2.7: FT-IR spectra of coatings PEG-silane, COOH-silane and functional 
MNPs C10a, C10b (spectrum 1,2,3,4 respectively). 
 
 
 
Table 2.2: Vibrations of coating reagents (PEG-silane, COOH-silane) and 
functional MNPs C10a, C10b 
 IR vibrations (cm
-1
) 
PEG-silane (90%) 2865 (CH2, CH3),1456 (CH2 bend), 1349 (CH3 bend), 1083 
(C-O), 820 (Si-O)  
COOH-silane (45%) 3600-3000 (H2O), 2956, 2840 (CH2, CH3), 1577(COO
-
 as), 
1405 (COO
-
 s), 1109 (C-O)  
C10a sample 2905, 2841 (CH2, CH3 stretches), 1590 (COO
-
 as), 1352 
(COO
-
 s),  1085 (C-O), 540 (Fe-O-Fe, Fe-O-Si) 
C10b sample 2864 (CH2, CH3), 1589 (COO
-
, as), 1396 (COO
-
, s), 1087 
(C-O), 1010 (Si-O), 552 (Fe-O-Fe, Fe-O-Si) 
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the spectra of functional MNPs, such as carboxylate (COO-) groups (anti-symmetric 
and symmetric stretches), ether (C-O) groups. The vibrations of Fe-O groups are found 
in the spectra of C10a and C10b samples.  
 Fig. 2.8 shows the combination of the spectra of various functional MNPs samples 
with the volume percentage of COOH-Silane in the range from 10-100%. 
Characteristic vibrations of alkyl chains, carboxylate groups, ether groups and Fe-O 
groups were all found.  
Transmission electron microscopy: A TEM image of C10a particles is shown in Fig. 
2.9. The image indicates that the particles synthesized by sonication were not 
homogeneous. In general, the size of these particles is around 15 nm.  
Dynamic Light Scattering and Zeta Potential: The stability of ferrofluids is an 
important parameter for applications, hence their properties were characterized by 
dynamic light scattering (DLS) and ZP. Table 2.3a, shows the hydrodynamic diameter 
and zeta potential of functional MNP samples synthesized. The hydrodynamic 
diameter of ferrous fluids is higher than the size measured by TEM image due to the 
layer of solvent (water) surrounding the MNPs. As shown in Table 2.3a, no relation 
between hydrodynamic diameter and the percentage of COOH-silane is found. This is 
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Fig. 2.8: Comparison of FT-IR spectra of functional MNPs synthesized from PEG-
silane and COOH-silane coating reagents with different percentages of COOH-
silane: 10%, 20%, 30%, 40%, 50%, 100% (respectively corresponding to C10a, 
C20a, C30a, C40a, C50a, C100a samples). 
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still an unsolved question and further study needs to be done to clarify this 
phenomenon. However, with a hydrodynamic diameter varying from 27-52 nm, these 
systems are suitable for the coupling of proteins or other bio-entities. 
Zeta potentials of ferrofluids are negative (from -22 mV to -48 mV), indicating a high 
degree of stability. Especially the C100 samples are very stable (ZPC100a= -48mV, 
ZP(C100b= -35mV), explained by many negatively charged groups on the surface of 
MNPs. Notice that the functional group on the particles’ surface is carboxylate (COO-) 
which is strongly solvated by water molecules in aqueous solutions. A decrease in the 
values of ZP was found when storing the MNPs in the solution, possibly due to the 
reaction between carboxylate groups (-COONa) and carbon dioxide (CO2) in the air 
leading to the formation of -COOH groups. However, these samples are still stable 
after two weeks (Table 2.3b). Both synthetic methods yield particles with considerably 
different ZP. For example, the ZP of C100a solution is more negative than the value of 
C100b solution, suggesting that C100a sample in the solution is more stable than 
C100b and a thicker coating layer is formed on C100a particles. This is also confirmed 
by DLS (Table 2.3b). 
For biomedical applications, the particles need to be stable under various pH 
conditions. So, the stability of the ferrous fluids was investigated in a pH range from 4 
to 10. The pH of the solution was adjusted by 0.01M NaOH solution and 0.01M HCl 
solution. Before adjusting the pH, 1mM NaH2PO4 solution was added to the 
ferrofluids. By this way, the ferrofluid was buffered with 1 mM NaH2PO4. Note that 
 
Fig. 2.9: TEM image of C10a samples. 
 
S y n t h e s i s  o f  M N P s  f o r  p r o t e i n  c o u p l i n g |  4 7  
 
the addition of NaH2PO4 could cause a slight decrease in ZP. C10 samples were 
chosen for this study because they are the most appropriate samples to couple with  
proteins as explained in Section 2.2.3). Other samples have much more carboxylic 
groups, leading to the high possibility to form cross-links between protein and NPs.    
Data of zeta potentials of C10a and C10b samples in the pH range from 4-10 are 
shown in Fig. 2.10. At a concentration of 0.0625 mg/mL, the values of the 
hydrodynamic diameter of all samples are approximately 40 nm, suggesting that they 
Table 2.3: Properties of ferrofluids based on different kinds of carboxylic 
functional MNPs, depending on i) the percentage of COOH-silane component and 
ii) the method of synthesis. 
 
a)    b)  
Samples 
0.5 
mg/mL 
Hydrodynamic 
diameter (nm) 
ZP 
(mV) 
 Samples  
(c=0.5 mg/mL 
H2O) 
100% COOH-
silane 
C10a 52 -34 
 
 
C100a C100b 
C20a 32 -23  
Hydrodynamic 
diameter (nm) 
49 17 
C30a 34 -22  
ZP 
(mV) 
Newly 
synthesized 
-48 -35 
C40a 25 -24  
After 14 
days 
-20 -21 
C50a 27 -38 
 
 
pH 9 10 
C100a 49 -48 
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Fig. 2.10: Zeta  potential values of C10a and C10b suspensions as a function of 
pH. 
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are not affected much by the pH. Both C10a and C10b samples are stable in solution 
with zeta potentials ranging from -22.5 to -35.2 mV (C10a) and from -18.0 to -29.8 
mV (C10b). Similar to the zeta potentials of C100a and C100b shown above, C10a 
suspensions were slightly more stable than C10b ones. The data also show a decrease 
of zeta potentials as the pH increases. This is expected because more carboxylic 
groups will convert to charged carboxylate groups since the solution is more basic.   
Vibrating Sample Magnetometer: Fig. 2.11 shows magnetization curves of the 
C100a and C100b samples at 298K, indicating superparamagnetic behavior of theses 
functionalized IONPs. The high values of saturation magnetization (Ms(C100a) = 
65.41 emu/g, Ms (C100b) = 83.81 emu/g) suggests the presence of magnetite Fe3O4 in 
the core. Especially, the Ms value of C100b particles is close to the value of bulk 
magnetite (92-100 emu/g) [156].  
 2.3.3. Quantification of BSA binding onto functionalized IONPs 
During the coupling of protein to functional IONP samples, there was a high tendency 
to form cross-links between magnetic NPs and BSA molecules. This readily happened 
especially with the magnetic particles having many carboxyl groups on the surface. In 
this case, several functional IONPs are linked together through BSA molecules, 
forming a heavy conjugate which was precipitated out of the solution. For this reason, 
IONPs functionalized with only 10% COOH-silane and 90% PEG-silane were chosen 
for further study of the coupling process later. The sample C10b was used instead of 
the sample C10a because stirring process (method b) rendered the solution mixed 
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Fig. 2.11: Magnetization curves of C100a and C100b samples 
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better. This leads to a formation of more uniformly coating layer on the surface of 
IONPs.   
Before the determination of the amount of bound protein, a test sample consisting of a 
mixture of BSA and functional MNPs was used to check the accuracy of the 
calibration curve in the presence of magnetic NPs. The experiment and the results are 
shown in SI, confirming that the presence of magnetic NPs do not affect the results of 
Bradford assay.  
BSA molecules were coupled to the C10b sample in the presence of activating 
substances EDC and NHS. After the reaction, the particles were separated, washed and 
stored in PBS buffer solution at pH=7. The hydrodynamic diameter was 36 nm and the 
zeta potential -25 mV.  
Through the reaction, it is important to avoid cross-linking between MNPs and protein 
molecules. Because there are many carboxyl groups on the MNPs surface and many 
amine groups in BSA, several MNPs and several protein molecules have a tendency to 
react together, forming very heavy particles. In this case, these  particles will 
precipitate and cannot be dispersed again. It is clear that there are many parameters 
that can affect the coupling, such as the concentration of functional MNPs, the amount 
of reactants MNPs and BSA, the amount of EDC and NHS, reaction time. For these 
reasons, many experiments were carried out to find the optimal conditions of the 
coupling process as described in Section 2.2.3. The optimized conditions are given in 
Table 2.4. 
After the reaction, all magnetic particles were separated, and then the volume of the 
BSA-MNPs solution and the volume of the supernatant were increased to 5mL. 
Different aliquots of each protein sample (in the solution of protein – coupled MNPs 
and the supernatant) were used for Bradford assay because the method is very 
sensitive. The amounts of BSA in 5 mL solution were calculated by using the 
calibration curve and are listed in the Table 2.5. 
Table 2.4: The reaction conditions of some coupling experiments (EDC solution: 
20mg/mL; NHS solution: 20mg/mL ; BSA solution (in MES)  2.5 mg/mL). 
 Amount 
of C10b  
sample 
Volume of 
EDC 
solution 
Volume 
of NHS 
solution 
Amount of 
BSA 
Time 
reaction 
Method 
of 
coupling 
Ex1 3 mg 50 µL 50 µL 
 
100 µg 
 
2h Shaking 
Ex2 3 mg 50 µL 50 µL 
 
100 µg 
 
2h Stirring 
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In Ex1 and Ex2, the calculation of the amount of BSA bonded to the MNPs showed a 
good agreement between the two methods of determination (direct and indirect ones). 
The amounts of reacted BSA ranged from 48.3-58.6 µg in Ex1 and from 54.6-63.1µg 
in Ex2. On average, there is 18.2-21.0 µg of BSA on the surface of 1 mg MNPs in 
Ex2. 
Note that the experimental conditions of Ex1 and Ex2 were the same but the method of 
coupling differs. So, the higher amount of reacted BSA in Ex2 indicates that the 
stirring method is preferred for the coupling due to its higher efficiency.  
Although only the coupling and determination of BSA were investigated, this work 
can be extended to other types of proteins such as antibody/antigens.  
Table 2.5: Amount of BSA coupling to 3 mg MNPs was determined by Bradford 
assay. The assays were performed in both the pellet and the supernatant after 
coupling reaction.  
 
Experiment 
Existing 
form of 
BSA 
Volume 
of protein 
sample 
(mL) 
 Total 
amount of 
coupled 
BSA in the 
pellet (µg) 
Total 
amount of 
free BSA 
in the 
supernatant 
(µg) 
Total 
amount of 
BSA (µg) 
coupling to 
3 mg MNPs 
(% BSA 
reacted) 
Ex1 
Coupled to 
MNPs 
0.30 63  
58.6 ± 4.1 0.45 60 
0.60 52.5 
Free in 
supernatant 
0.15 56.7 
51.7 ± 8.3 48.3±8.3 
0.30 63.3 
0.45 44.4 
0.60 42.5 
Ex2 
Coupled to 
MNPs 
0.15 73.3  
63.1 ± 6 
0.30 65 
0.45 60 
0.60 54.2 
Free in 
supernatant 
0.15 50 
45.6 ± 3.9 54.6±3.9 
0.30 45 
0.45 48.9 
0.60 38.3 
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2.4 Conclusions and outlook 
2.4.1 Conclusions 
The goals of this chapter were the synthesis of functional magnetic nanoparticles 
(MNPs) and using these particles to couple to proteins (Bovine serum albumin). One 
of the main issues was to quantify the amount of protein bounded on the magnetic 
particle surface.  
First, magnetite nanoparticles (with a coating layer of n-octylamine) were synthesized 
by the forced hydrolysis method. Next, the particles were functionalized to yield 
MNPs with carboxyl functionalities on their surface. The MNPs dispersed well in 
water yielding very stable ferrofluids. The structure of the coating layer of the MNP 
surface was studied by FT-IR spectroscopy, the sizes were confirmed by TEM, 
magnetization curves were recorded by VSM and the properties of ferrofluids were 
investigated by DLS and ZP. At the end, we were able to successfully couple BSA to 
the MNPs giving conjugates that were stable in PBS buffer solution. Using the 
Bradford assay, a BSA calibration curve was build and used to detect BSA with a 
detection range of 0.5-15µg BSA. For quantification of coupled BSA on the MNP 
surface, Bradford assays were performed in both the suspension of protein - MNPs 
conjugates and the supernatant. Generally, about 20 µg of BSA could be bound to 1 
mg of MNPs. 
2.4.2 Outlook 
A series of functional MNPs were synthesized based on two coating reagents: PEG-
silane and COOH-silane and the method of synthesis (sonicating and stirring method). 
Several characterizations such as DLS and ZP measurements were done in order to 
explore the dependence of the properties of particles on their coating components. 
However, no clear relation was observed. Further studies are needed to clarify.  
In general, the amount of BSA coupled to MNPs was quantified, however there are 
still questions to answer. Other techniques used to determine protein need to be 
applied and compared with the Bradford’s method. One possible approach is using 
fluorescent dyes to label protein and the dye-tagged protein - MNP conjugation will be 
determined by fluorescence measurements. 
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2. 5. Supporting information 
A. Experimental section 
Materials: All chemicals were purchased from standard supplies and used as received 
without further purification. Milli-Q water (18 MΩ cm
− 1
) was used to prepare all 
aqueous solutions. Protein bound MNPs were washed by 50 mM pH7 PBS buffer 
solution and also stored in this kind of buffer solution. 50 mM pH 5.5 MES buffer 
solution was used as solvent in all experiments to determine the amount of protein in 
all protein samples.  
Magnetic columns (MS columns) were purchased from Miltenyi Biotec. 
Equipment and characterization: Transmission electron microscopy measurements 
were performed on a 80 kV Zeiss EM-900 using 300 mesh Formvar-coated copper 
grids. Distribution data were calculated by ImageJ software. UV–Vis Spectrometry 
was performed on a Perkin Elmer Lambda 900 spectrometer. Magnetic properties of 
the nanoparticles were characterized by a superconducting quantum interference 
device magnetometer (SQUID, Quantum Design MPMS XL-5). Vibrating sample 
magnetometry (VSM) experiments were conducted on a VSM Maglab setup from 
Oxford Instruments. Fourier transform infrared (FT-IR) spectra were obtained using a 
Bruker Alpha FT-IR spectrometer equipped with a Platinum ATR module. Dynamic 
light scattering and zeta potentials were measured on a Brookhaven 90plus particle 
analyzer. The internal detector was positioned at 90
o
. 
Synthesis of  superparamagnetic IONPs: The synthesis method of magnetite 
nanoparticles is based on the forced hydrolysis technique described by Brullot et al. 
[63]. Ferric chloride (FeCl3) is used as a salt precursor, ethylene glycol as a solvent 
and a reductant. n-Octylamine functions as both a capping agent and a preliminary 
coating layer. Typically, a ferric solution was prepared by dissolving 2.4 g of 
anhydrous FeCl3 in 10 mL of ethylene glycol and 3.5 mL of Milli-Q water at 50 
o
C. 
On the other hand, 25 mL of octylamine was dissolved in 37.5 mL of ethylene glycol, 
then the solution was heated to 150 
o
C. To this solution, the ferric solution was added, 
and then the mixture was further heated, refluxed at 180 
o
C for 24h. After the reaction, 
the particles were precipitated by using a magnet, quickly washed with acetone and 
dried in vacuum to obtain a powder of iron oxide with a typical quantity of 1 g.  
It is important to note that the synthesized IONPs are coated by a layer of n-
octylamine. Therefore, if particles are washed too many times with acetone, the layer 
coating will dissociate in acetone. IONPs will loose the coating layer and therefore 
cannot be redispersed in toluene later. 
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B. Bradford’s method 
Bradford’s method is one of the most common assays for protein quantification 
because of its rapid and sensitive characteristics.  
Principle of Bradford’s method: The Bradford reagent contains the dye Coomassie 
Brilliant Blue G-250 (CBB) that can simultaneously exist in three different forms: 
anion, neutral species and cation with different absorption maximum (595, 650 and 
470 nm, respectively) [154]. The structure of neutral form is shown in Fig. 2S.1. 
 
Existing forms:  Anion (blue)    Neutral species (green) Cation (red) 
Absorption maximum: 595nm   650 nm      470nm 
 
The concentration ratio of existing forms of the dye CBB is pH-dependent in which 
CBB is almost entirely doubly protonated (cationic form) at pH 0.30, and deprotonated 
(anionic form) at pH 1.25 [154], [157]. So, in the acidic environment of protein 
reagent (pH=0.5), only cationic and neutral forms exist and the presence of anionic 
form is not found.  
Because only anionic species of CBB G-250 are able to bind to protein due to their 
electrostatic and hydrophobic interaction [154], [157], the addition of protein to CBB 
solution leads to the conversion of neutral and cationic species to anionic species. As a 
result, the absorption maximum of the dye is shifted from 465nm (cation) and 650 nm 
(neutral species) to 595 nm. The number of proteins can be determined from the 
 
Fig. 2.S1: The structure of the neutral form of CBB. The anion will be obtained 
when the acid dissociation occurs at -SO3H group. 
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increase in absorbance at 595 nm. The protein dye complex has a high absorption 
coefficient, explaining the high sensitivity of the method.  
Preparation of protein reagent (CBB solution): 100 mg of CBB G-250 was 
dissolved in 50 mL of 95% ethanol. To this solution, 100 mL of 85% (w/v) phosphoric 
acid (H3PO4) was added. Then, the volume is filled up to 1 L with Milli-Q water to 
form a solution of 0.01% (w/v) CBB, 4.7% (w/v) ethanol, and 8.5% (w/v) phosphoric 
acid [153].  
Calibration curve: Standard protein solutions were prepared following the procedure 
in Section 2.2.4 (preparation of protein sample). Twelve standard protein solutions 
containing from 0.5 to 15μg of BSA were prepared from 25μg/mL BSA solution in 
MES as follows: 
 
Table 2.S1: Preparation of standard protein samples from 25μg/mL BSA solution. 
Standard 
samples 
Volume of 25μg/mL 
BSA solution (μL) 
Volume of 50 mM pH 5 
MES buffer solution added 
(μL)  
Amount of 
protein (μg) 
STD1 20 580 0.5 
STD2 40 560 1.0 
STD3 60 540 1.5 
STD4 120 480 3.0 
STD5 180 420 4.5 
STD6 240 360 6.0 
STD7 300 300 7.5 
STD8 360 240 9.0 
STD9 420 180 10.5 
STD10 480 120 12.0 
STD11 540 60 13.5 
STD12 600 0 15.0 
 
To each standard protein sample, 900µL of the protein reagent (CBB solution) was 
added and its absorption was measured with a reference cuvette containing 600 μL of 
MES and 900 μL of CBB. The absorbance values at maximum wavelength (normally 
595nm) were plotted versus the amount of protein (μg), forming the BSA calibration 
curve. 
Fig 2.S2a shows the UV-Vis spectra of CBB in the absence of protein and in the 
presence of protein with a reference cuvette of water. The spectrum of CBB has a 
maximum wavelength at 650 nm, referring to the absorption maximum of neutral 
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species. No absorption maximum at 595 nm was recorded, meaning there is no the 
presence of anionic species (or negligible amount) in the protein reagent.  
When adding proteins, the absorbance of the solution increased and the absorption 
maximum was gradually shifted to the wavelength of absorption maximum of the 
anionic species. This is explained by converting a part of the neutral species to anionic 
ones when adding protein due to the fact that anionic species can make strong 
interactions with protein molecules.  
Fig 2.S2b shows a similar result in which the reference cuvette consists of MES buffer 
solution and CBB reagent. Absorption maxima are found at 588 nm in all spectra 
corresponding to the formation of anionic species.  
The values of the absorption maximum of standard samples (at 588 nm) are listed in 
Table 2.S2 and are plotted versus the amount of BSA protein (µg) (Fig 2.S3.), creating 
the BSA calibration curve.  
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Fig 2.S2: The result of the Bradford assay of standard samples with reference cuvette 
of water (a) or the mixture of MES(600µL) and CBB(900µL) (b). 
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Table 2.S2: The absorbance of standard samples in Bradford assays at absorption 
maximum 
Standard 
samples 
Amount of protein 
(μg) 
Absorbance at maximum 
wavelength (588nm) 
STD1 0.5 0.03872 
STD2 1.0 0.0734 
STD3 1.5 0.10604 
STD4 3.0 0.16208 
STD5 4.5 0.24163 
STD6 6.0 0.32494 
STD7 7.5 0.33816 
STD8 9.0 0.38618 
STD9 10.5 0.42296 
STD10 12.0 0.44394 
STD11 13.5 0.4286 
STD12 15.0 0.45895 
 
There is a small non linear trend at the end of the curve (Fig 2.S3a), however the high 
correlation factor (R
2
=0.993) proves the high accuracy of the calibration. 
With the data from six first standard samples, the calibration curve is linear (Fig 
2.S3b). This calibration was used to calculate the amount of protein in Bradford 
assays.  
y = 0.046 *x + 0.022   (R
2
=0.9942) (2.1) 
where : y : the absorbance at absorption maximum,  x: the amount of BSA (µg) 
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Fig 2.S3: The calibration curve of BSA in Bradford assays (buffer MES 50mM, pH 
5.5) in the range a) from 0.5-15µg BSA, b) from 0.5-6µg BSA 
 
 
Note that these experiments were carried out in MES buffer. Every solution was 
prepared in MES, containing protein and functional MNPs solutions. The Bradford 
assays can be performed in other conditions, such as PBS (pH 7.0). In this case, new 
calibration curves should be measured again.  
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Test sample for calibration curve: A test sample consists of a mixture of 3 mg of 
functional MNPs (C10b) and 100 µg of BSA protein. These components were 
dissolved in MES and the solution was diluted up to 5 mL. Different quantities 
(0.15mL, 0.3mL, 0.45mL and 0.6mL) of the test sample (respectively corresponding to 
3μg, 6μg, 9μg and 12μg BSA) were chosen to do Bradford experiment. Then, UV-Vis 
spectra were compared to the spectra of standard samples containing the same amount 
of protein (STD4, STD6, STD8, STD10). These spectra are shown in the Fig. 2.S4. 
The similarity of these spectra suggests: i) the MNPs have no contribution in these 
UV-Vis spectra) and ii) the high accuracy of BSA calibration curve.  
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Fig. 2.S4: Comparison of results of Bradford experiment for test samples and standard 
samples containing the same amount of BSA (solid lines refer to spectra of test 
samples, dash lines refer to spectra of standard samples) 
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Chapter 3 
Synthesis of iron oxide/gold 
core/shell nanoparticles 
 
 
Dr. M. Bloemen prepared oleic acid coated IONPs and helped with the synthesis of 
gold coated IONPs in the organic phase. Prof. Dr. J. Billen performed TEM 
measurements. 
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Abstract 
In this chapter, we present the synthesis of water-dispersed gold nanoshells by two 
approaches: synthesis in aqueous phase and organic phase. Gold nanoshells show 
surface plasmon resonance peak varying from 528 nm to ~700 nm. Besides, 
mesoporous silica component was also introduced to design versatile multilayer 
nanoshells. By combining many interesting properties into one single particle, the 
obtained nanostructures show their potential in advanced applications. 
3.1 Introduction  
Magneto-plasmonic nanostructures combine magnetic and plasmonic properties in one 
material. Although either magnetic [5], [50], [64], [85], [95], [99], [141], [158]–[163] 
or plasmonic [134], [164]–[169] nanoparticles (NPs) have been intensively studied in 
biomedical applications for a long time, magneto-plasmonic nanostructures have been 
given attention only recently. The integration of magnetic and plasmonic components 
results in many interesting properties such as a strong interaction with light and 
external magnetic fields. Fig. 3.1 shows the interaction of magneto-plasmonic core-
shell nanoparticles with photons, AC magnetic fields and DC magnetic fields. The 
characteristic feature of the plasmonic component is its interaction with light. Incident 
photons can be: i) absorbed to generate localized surface plasmon resonances (LSPR) 
and generate heat [170] or ii) scattered to generate scattering contrast [171]. External 
magnetic fields can be used to control the movement of particles and provide extra 
contrast in magnetic resonance imaging (MRI) [170]. AC magnetic fields can also be 
absorbed to generate heat through several loss processes [20]. 
Interestingly, the hybrid materials do not only possess the properties of each 
component, but some properties are also enhanced. For example, oscillating magnetic 
fields with frequencies of kHz to MHz induce hyperthermia in Fe3O4 nanoparticles 
[13], [146] whereas the hyperthermia can be achieved at lower frequencies (44 Hz to 
430 Hz) for Au–Fe3O4 core/shell nanocomposites [20]. Au NPs smaller than 2.5 nm do 
not show LSPR bands but 0.5 nm Au shells can exhibit LSP resonances [23]. 
Furthermore, Au NPs show a plasmon peak around 520 nm [121] whereas magneto-
plasmonic nanostructures show plasmon peaks in a wide spectral range (530-1200 nm) 
[136], [172]. 
To design multifunctional (magnetic and plasmonic) nanostructures, it is possible to 
perform one of the following approaches: [61] 
- Assembling several mono-functional entities in a larger assembly.  
- Integrating the required functional components into a single entity.  
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Some examples of the first approach are: Au NPs and iron oxide nanoparticles 
(IONPs) that are embedded in a polymer or silica coating [173]–[175], or the assembly 
of Au NPs and IONPs by a linker composed of bifunctional small molecules to make 
nanoparticle multilayers [176]. In the second approach, two components in the core-
shell particles are very close, leading to a maximal interaction between magnetic and 
plasmonic components. Moreover, many applications in biomedicine, such as 
controlled drug delivery, diagnostic and therapy require the movement of these 
nanostructures as single entities. Therefore, we opted for the synthesis of iron oxide-
gold core-shell nanoparticles (IOGNPs). Furthermore, for biomedical applications, it is 
critical that the synthesized IOGNPs are biocompatible and water-dispersible. Finally, 
the shell thickness needs to be controlled to obtain a tunable plasmonic peak. 
Formation of water-dispersed IOGNPs can be achieved by two general approaches: i) 
direct synthesis of Au nanoshells in aqueous phase, or ii) synthesis of Au nanoshells in 
an organic phase followed by phase transfer to water.  
3.1.1 Synthesis of Au nanoshells in water 
For the first approach, Au nanoshells are formed by the reduction of Au precursor 
(HAuCl4) onto the surface of IONPs in the aqueous medium. Before Au shell 
deposition, IONPs need to undergo a surface functionalization. The purpose of adding 
a coating layer on the surface of the IONPs is:  
- The functional groups are able to bind Au
3+
 ions before the reaction and gold 
after the reaction. As a consequence, the reaction preferably takes place on 
the surface of IONPs to form Au nanoshells instead of somewhere in the 
solution to form isolated Au NPs.  
 
Fig. 3.1: Magneto-plasmonic core-shell nanoparticles and their interactions with 
light (A), AC magnetic fields (B) and DC magnetic field (C). Reprinted with 
permission from Ref. [183]. 
 
  
 
 
6 2  |  S y n t h e s i s  o f  i r o n  o x i d e / g o l d  c o r e / s h e l l  N P s  
 
- To avoid the migration of Au atoms into the iron oxide core [33]. This 
migration would lead to a distortion of the core and therefore significant 
decrease of the magnetic properties.  
The coating layer can be composed of i) polymers [146], [177]–[179], ii) small 
molecules [33], [75], [85], [89], [101], [180], or iii) a (mesoporous) silica shell [102], 
[173], [181]. Fig. 1.13 showed an overview of surface functionalization of IONPs.  
i) The use of polymers as coating agents are favorable for some applications because 
of their biocompatibility. However, the disadvantages in control of the shell thickness 
and the leak of the core (due to the weak interaction between IONPs and polymers) 
limit their potential in advanced applications. Therefore, there were only few cases in 
which polymers were reported as coating agents for gold coating, such as polyaniline 
[177] and poly-L-histidine [178].  
ii) Contrary to polymers, organic molecules such as alkoxysilane, carboxylate, 
phosphonates are widely used in functionalization because they bind covalently to 
IONPs. Moreover, these organic molecules can form a thin coating layer which has no 
influence on the magnetization of IONPs. The availability of many organic molecules 
as coating agents is also an advantage because they can provide different functional 
groups (such as amino, thiol, carboxylic, hydroxyl) for different purposes. For gold 
coating, these organic molecules often have two functional groups: one is able to bind 
to IONPs (carboxylate/phosphate/catechol/alkoxysilane) and another is able to 
coordinate to gold. Although both amino and thiol groups have high affinity for gold, 
only amino-terminated reagents are often used to form coating layers. This is due to 
the low polarity of thiol groups leading to a low solubility of functionalized particles in 
aqueous medium. Some common amino-terminated reagents are 3-
aminopropylphosphonic acid [33], dopamine [92], [93] and alkoxysilane [100], [101], 
[182].   
iii) Prior to the gold coating process, silica or mesoporous silica (mp-SiO2) shells with 
different thickness can also be used as coating agents for IONPs. The most popular 
method used to grow a silica shell is the Stöber method based on the hydrolysis and 
condensation of a silica precursor such as TEOS/EtOH in the presence of a base (NH3, 
NaOH,…) [103]. During the growth of the silica shell, a large excess of surfactants 
(e.g., cetyltrimethylammonium bromide (CTAB)) [7], [104], [105]) can be added to 
form mp-SiO2 shells which can be exploited as fluorescent labeling or drug delivery 
carriers [7], [181].  
The presence of SiO2 shells increase the particle size before gold coating, leading to an 
increase of IO-SiO2 core/Au shell ratio.  The increase of core/shell ratio causes a red-
shift of the LSPR band of the Au shells. The position of the band can vary from the 
visible to the near-infrared (NIR) region [136], [183]. For example, IOGNPs exhibit a 
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clear SP band at 535 and 550 nm for different core sizes and Au shell thickness [184], 
[185] whereas iron oxide – silica – gold NPs might exhibit a plasmonic peak at 1200 
nm [136] (see Section 1.4.3). The red-shift of the plasmonic peak to the NIR region 
plays an important role in optical biomedical applications such as in vivo optical 
imaging and photothermal therapy [134], [186], [187] because water and most 
biological materials including hemoglobin, are transparent (in active) in NIR region 
[188].  
In order to prepare Au nanoshells, HAuCl4 is reduced with relatively strong reductants 
such as citrate  [189], [190] or hydroxylamine (NH2OH) [171], [191]. Furthermore, the 
reaction can be facilitated by sonication as well [33], [192] . Au atoms prefer to 
deposit on the surface of NH2-functionalized IONPs because amino groups can bind to 
Au
3+
 before the reaction and newly formed Au shells after the reaction. However, 
during the reaction, there is always the possibility that isolated Au NPs can be formed 
in the solution instead of Au nanoshells and as a consequence the product is always a 
mixture of Au NPs and Au nanoshells.  
To avoid these disadvantages, we opted for the approach described in scheme 3.1. 
Briefly, small negatively charged Au seeds (1-3 nm), prepared by the Duff method 
[193], are attached on the surface of NH2-functionalized IONPs before undergoing the 
gold coating process. Because alkylamines mainly exist in positively charged form (R-
NH3
+
) at pH<10, the dominant interaction between Au seeds and NH2-functionalized 
IONPs is electrostatic rather than coordinative in nature [194]. Also according to 
Westcott [194], small Au seeds can strongly attach to the surface of the IONPs and the 
Scheme 3.1: Schematic of gold coating approach using gold seeds.  
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coverage ratio can go up to ~ 30%. These small Au seeds do not only act as seeds for 
the growth of nanoshells, but also act as the catalyst for the reduction. Hence, a weak 
reductant such as HCHO [101], glucose [93], CO [100] is sufficient for the reaction. 
The use of a weak reductant can be beneficial as the formation of Au nanoparticles in 
the solution is avoided. Moreover, the shell thickness can be easily controlled by 
varying the amount of reactants.  
3.1.2 Overview of synthesis of Au nanoshells in an organic phase 
For the second approach, synthesis of Au nanoshells in an organic phase, a well-
known method is the direct growth of Au shells on the surface of IONPs at elevated 
temperature [23]. First, oleic acid-coated IONPs are synthesized that act as seeds for 
gold deposition. Then, gold is deposited onto the surface of the IONPs by the 
reduction of gold (III) acetate at 180-190 
o
C in the presence of oleylamine and oleic 
acid as capping agents. This method is used to synthesize highly monodisperse 
nanoparticles [23], [184], [185]. The reaction is illustrated in Scheme 3.2. 
The deposition of gold onto IONPs takes place together with the partial desorption of 
surfactants (oleic acid, oleylamine) from the IONPs, followed by re-adsorption of 
surfactants onto the gold surface. The temperature plays an important role here 
because all processes are thermally activated. More reduced gold (III) ions lead to the 
formation of a complete Au nanoshell and the latter is surrounded by a coating layer of 
oleylamine due to the high affinity of Au for amino groups. This coating layer helps 
IOGNPs to disperse well in organic solvents (heptane). This approach can be applied 
to synthesize iron oxide-gold NPs with a core size from 5-15 nm and a shell thickness 
from 0.5–2.0 nm [23]. The thickness of Au nanoshells is tunable by changing the 
concentration of Au precursor and the reaction time [23]. However, for biomedical 
applications, hydrophobic Au nanoshells need to be transferred from the organic phase 
to an aqueous phase. 
Scheme 3.2:  The schematic of gold depositing onto IONPs in the organic phase. 
Reprinted with permission from Ref. [23].  
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Here, the synthesis of IOGNPs following two approaches: synthesis in the aqueous 
phase (i) and organic phase (ii). Furthermore, iron oxide – gold – silica multilayer 
nanoshells (IO-Au-SiO2 NPs) were prepared. Although the synthesis of gold 
nanoshells with tunable plasmon properties has been intensively studied since first 
synthesized by Oldenburg in 1998 [195], to our knowledge, very little work in the 
integration of gold nanoshells, mesoporous silica shells and magnetite core in one 
single particle has been done. These multilayer nanoshells with many interesting 
properties can be a potential candidate in the search of a new class of multifunctional 
nanodevice for advanced biomedical applications such as theranostic nanomedicines.  
Scheme 3.3 shows the summary of all syntheses presented in this chapter. All prepared 
NPs were characterized by various techniques including TEM, SEM, UV-Vis-NIR 
spectroscopy, SQUID/VSM and Zeta Potential.  
 
Scheme 3.3: Summary of syntheses of magnetic core-shell nanoparticles starting 
from IONPs. 
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3.2 Experiments 
3.2.1 Chemicals 
All chemicals were purchased from standard suppliers and were used as received 
without further purification. Preparation of all solutions including buffer solutions, Au 
seed solution, HAuCl4 plating solution are described in SI.  
3.2.2 Synthesis of IONPs 
Oleic acid coated IONPs were synthesized on a large scale as reported earlier [52], 
[75]. The obtained particles were dispersed in heptane and stored in a flask. Details 
can be found in the supporting information (SI).   
3.2.3 Functionalization of IONPs 
Dopamine functionalization of IONPs:  
100 mg of oleic acid coated IONPs (50 mg/mL heptane) were dispersed in 50 mL of 
tetrahydrofuran (THF) in an Erlenmeyer flask. The solution was protected in argon 
atmosphere and then sonicated. To this solution, some amounts of aqueous 30 mg/mL 
dopamine hydrochloride solution (1.5 mL, 2 mL, 1.5 mL) were alternatively added in 
2 hours. The solution was continuously sonicated for one hour. After one hour, the 
particles were magnetically separated and then dispersed again in water. This cycle 
was repeated three times and finally dopamine-HCl coated IONPs were dispersed in 
water (10 mg/mL) for storage.   
The obtained solution has a very low pH value (pH~2) because of the present of HCl, 
which is not suitable for Au seed deposition later. The particles were collected and 
washed by centrifugation (11.000 rpm, 20 minutes, three times). Finally, the particles 
were dispersed in PBS buffer solution (10 mM, pH 6) at a concentration of 2 mg/mL in 
order to protonate –NH2 groups.  
mp-SiO2 functionalization of IONPs 
mp-SiO2 coated IONPs were synthesized by the Stöber method following a published 
protocol with minor modifications [52], [181]. In a typical procedure, IONPs (12 mg) 
were dried from heptane solution and dissolved in 0.5 mL of chloroform. 
Simultaneously, 5 mL of 0.11 M aqueous CTAB solution was prepared at 35 
o
C and 
added to the chloroform solution. The mixture was stirred vigorously for 2 hours to 
form a turbid brown solution. Then, the mixture was heated up to 61.5 
o
C and kept 
stirring for 20 min to evaporate completely the chloroform, resulting in a transparent 
dark brown solution. After that, the solution was transferred to a 100 mL round flask 
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containing 45 mL of water and 0.3 mL of 2 M NaOH solution. The flask was 
connected to a condenser and heated up to 70 
o
C. To the solution, 0.5 mL of 
tetraethylorthosilicate (TEOS) and 3 mL of ethyl acetate were consequently added. 
The reaction completed after 3 hours. After removing ethyl acetate from the solution 
by rotary evaporation, the particles were separated by centrifugation and dispersed 
again in ethanol. This step was repeated several times to remove excess reactants. To 
extract CTAB from the silica shells, 40 µL of HCl 37 % was added to the dispersion 
and stirred at 60 
o
C for 3 hours or shaking overnight. The pH of the solution was tested 
by pH paper and should be around pH 1-2 to avoid dissolving the magnetic core [181]. 
Magnetic nanoparticles (MNPs) were separated and washed 3 times and then dispersed 
again in 20 mL at the concentration of 1 mg/mL.  
Next, mp-SiO2 shells were functionalized with (3-aminopropyl)trimethoxysilane 
(APTMS). In detail, mp-SiO2 coated IONPs (12 mg) were collected from ethanol and 
dispersed in 20 mL of toluene. To this solution, 0.1 mL of APTMS was added and the 
obtained solution was shaken overnight. APTMS-functionalized IONPs were separated 
from toluene by centrifugation (11.000 rpm, 10 minutes, three times). The obtained 
particles were dispersed in ethanol (2 mg/mL). 
To protonate –NH2 groups, the particles were collected by centrifugation and dispersed 
in PBS buffer solution (10 mM, pH 6) at a concentration of 2 mg/mL. 
3.2.4 Synthesis of Au nanoshells in aqueous phase  
This section describes the general method of gold coating on the surface of dopamine 
or mp-SiO2 functionalized IONPs. The method contains two steps: Au seed deposition 
on the surface of functionalized IONPs and Au shell growth. Preparation of Au seeds 
(ca. 2 nm) is described in SI.  
Au seed deposition:  
Prior to the Au seed deposition, amino-terminated functionalized IONPs were 
protonated, as described above, to strengthen their interaction with the Au seeds. Then, 
1 mL of functionalized IONPs (2 mg/mL) was mixed with 6 mL of Au seed solution 
and the mixture was shaken for 18 hours. Au seed-decorated IONPs were separated by 
centrifugation (11.000 rpm, 20 minutes) and dispersed again in water. This cycle was 
repeated several times to remove excess Au seeds.  
Au shell growth:  
Au-coated IONPs were produced by the reduction of AuCl4
-
 ions (44 µM) in a plating 
solution by 10 µL of formaldehyde onto Au seed decorated IONPs [100]. The reaction 
took place in 15 minutes and the product was separated by centrifugation after the 
reaction (11.000 rpm, 20 minutes, 3 times). Au coated IONPs were dispersed again in 
water for the characterization (0.2 mg/mL).  
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3.2.5 Synthesis of Au nanoshells in an organic phase 
Synthesis of Au nanoshells in an organic phase:  
IOGNPs were synthesized in an organic phase following a previously reported 
protocol with some modifications [185]. In detail, 100 mg of oleic acid coated IONPs 
were dispersed in 5 mL of heptane. This solution was mixed with gold acetate (1mmol, 
374mg), 1,2-hexadecanediol (3 mmol, 775mg), oleic acid (2 mmol, 505 µL), oleyl 
amine (2 mmol, 434 µL) and dioctyl ether (solvent, 20 mL). This mixture was heated 
to 180 
o
C and aged at that temperature for 30 minutes. After cooling down to room 
temperature, 150 mL of ethanol was added and the particles were separated 
magnetically. The supernatant is greenish at this point. A small amount of heptane (5 
mL) was added, which results in a red phase. After adding 100 mL ethanol, the phase 
turns blue, indicating aggregation of gold-containing particles. The particles were 
magnetically attracted and the supernatant was decanted. This process was repeated 
five times. 100 µL of extra oleylamine was added to ensure the dispersion of Au-
coated IONPs because these ligands might be washed away during purification. The 
nanoparticles were stored in heptane at a concentration of 10 mg/mL. 
Phase transfer: CTAB was used as a capping agent to transfer IOGNPs from organic 
phase to aqueous phase. In detail, 12 mg IOGNPs were collected by evaporating 
heptane, then the particles were dispersed in 0.5 mL of chloroform. To this solution, 5 
mL of aqueous 0.055 M CTAB was added and the mixture was vigorously stirred at 35 
o
C for 2 hours. Finally, the mixture was heated up to 61.5 
o
C and kept stirring for 20 
min to evaporate completely the chloroform, resulting in a transparent dark pink 
solution. 
3.2.6 Synthesis of IO-Au-SiO2 NPs 
Aqueous IOGNP solution was obtained by using CTAB as a ligand exchange agent as 
described in Section 3.2.5. 5 mL of aqueous IOGNP solution was added to a 100 mL 
round flask containing 45 mL of water and 0.3 mL of 2 M NaOH solution. The flask 
was connected to a condenser and heated up to 70 
o
C. To the solution, 0.5 mL of 
TEOS and 3 mL of ethyl acetate were subsequently added. The reaction was 
completed after 3 hours. After removing ethyl acetate from the solution by rotary 
evaporation, the particles were separated by centrifugation and dispersed again in 
ethanol. This step was repeated several times to remove excess reactants. 
To extract CTAB from the silica shells, 20 µL of HCl 37 % was added to the 
dispersion and stirred at 60 
o
C for 3 hours or shaking for 16 hours. The pH should be 
around pH 1-2 to avoid dissolving the magnetic core [181]. After collection by 
centrifugation (7.000 rpm, 15 minutes), the particles were washed three times by 
ethanol and then dispersed again in 20 mL of ethanol. 
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IO-Au-SiO2 NPs were functionalized with rhodamine B following a published 
protocol with minor modifications [52]. Firstly, rhodamine B isothiocyanate (RITC) 
was coupled to APTES before binding to m-SiO2 shells. The mixture of RITC and 
APTES (molar ratio 1:10) in ethanol was shaken for 2 days under dark conditions. 
Next, IO-Au-SiO2 NPs (12 mg) were dispersed in 20 mL of toluene. To this solution, 
0.4 mL of RITC-APTES solution was added and the obtained solution was shaken 
overnight. Rhodamine B functionalized IO-Au-SiO2 NPs were separated by 
centrifugation (11.000 rpm, 20 minutes). For the purification, the particles were 
dispersed in ethanol and then were collected by centrifugation (11.000 rpm, 20 
minutes). This step was repeated several times until the supernatant was colorless and 
its absorbance in UV-Vis spectrum was insignificant.  
3.2.7 Characterization 
Nanoparticles were characterized using transmission electron microscopy (TEM, 80 
kV Zeiss EM-900, 300 mesh Formvar on copper grids as substrate), scanning electron 
microscopy (SEM, XL30 FESEM FEG microscope), vibrating sample magnetometry 
(VSM, 300 K, Oxford instruments VSM Maglab), superconducting quantum 
interference device magnetometer (SQUID, Quantum Design MPMS XL-5), Zeta 
potential measurements (Zetasizer Nano from Malvern Instruments) and UV–visible 
absorbance measurements (Perkin- Elmer 900). 
All TEM images were analyzed by Image J software. 
3.3 Results and Discussion 
3.3.1 Synthesis of IOGNPs in aqueous phase 
Synthesis of Au seeds 
Fig. 3.2 shows a TEM image of small Au NPs and the histogram of size distribution 
(inset). A size analysis indicates the size of Au seeds is 2.4 ± 0.5 nm. The UV-Vis 
spectrum of the Au seed solution is shown in Fig. 3.3 (solid line). The spectrum does 
not exhibit a plasmon peak as expected because the size of particles is too small. This 
result is consistent with results published previously [193]. According to Ref. [23], 
[196], Au NPs with a small size do not show a LSPR band whereas bigger Au NPs 
(e.g., 5 nm) show a pronounced plasmon peak. For example, commercial products 
containing 5 nm Au NPs from Sigma Aldrich and Cytodiagnostics show LSPR peaks 
at 510-520 nm [197], [198].  
Synthesis of IOGNPs from dopamine functionalized IONPs 
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Superparamagnetic IONPs (mainly Fe3O4 with small amounts of Fe2O3) were 
synthesized as reported earlier [52], [75]. Fig. 3.3(a) shows a TEM image of oleic acid 
coated IONPs. The particles size is 8.6 ± 0.6 nm. 
IONPs were transferred from the organic phase (heptane) to the aqueous phase upon 
dopamine functionalization. After the reaction, functionalized IONPs disperse well in 
water (10 mg/mL) and the solution is acidic due to the present of HCl. A quick pH test 
of the solution by a pH paper indicated the pH value was 2. Fig. 3.3(b) shows the TEM 
image of dopamine functionalized IONPs which is similar to that of oleic acid coated 
IONPs since the organic thin layer of dopamine does not appear in the TEM image.   
Dopamine is attached strongly to the IONPs due to bidentate or bridge bidentate 
chelating interactions between iron ions on the surface and –OH groups of dopamine 
[199] (see Fig. 3.4). ZP measurement  indicates a positive potential of +25.8 mV. This 
high ZP value also confirms the high stability of a colloidal dispersion of dopamine-
functionalized IONPs in water [15]. 
Au seeds were deposited onto dopamine-functionalized IONPs under acidic 
conditions. The attachment is due to the electrostatics interaction between small Au 
NPs (negatively charged) and NH3
+
 groups of the coating layer [102], [174], as 
illustrated in Scheme 3.1. The attachment of Au seeds is confirmed by the ZP 
measurement of the particles after purification. Because synthesized Au seeds are 
negatively charged [182], [194], the ZP value of Au seed-decorated dopamine 
functionalized IONPs should change from positive (dopamine-IONPs +25.8 mV) to 
negative. Indeed, the negative ZP value of Au seed decorated NPs (-24.94 mV) is 
shown in Fig. 3.S2 (SI), proving the success of the attachment.  
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Fig. 3.2: (top) TEM image of Au seeds. The histograms of size distribution (inset) 
shows the Au seed size of 2.4 ± 0.5 nm. (Bottom) UV-Vis spectrum of Au seed 
solution. No LSPR peak is observed.   
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Fig. 3.3: TEM image of oleic acid coated IONPs (left, scale bar 50 nm) and 
dopamine functionalized IONPs (right, scale bar 20 nm). The inset shows the 
particle size of oleic acid-coated IONPs is 8.6 ± 0.6 nm.  
  
 
 
 
Fig. 3.4: The structure of dopamine coated IONPs 
 
  
 
 
 
Fig. 3.5: TEM images of Au seeds-decorated iron oxide-dopamine NPs (pH=6) 
(left) and iron oxide/dopamine-Au core-shell NPs (right). Scale bars are 20 nm. 
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TEM images of Au seed-deposited on dopamine-coated IONPs are shown in Fig. 
3.5(a). There are small Au NPs (1-3 nm) attached to IONPs, however there are also a 
lot of free Au seeds present. Furthermore, it seems as if the particles were embedded in 
a film of organic material. The Au seed-embedded film remained in the pellet after the 
centrifugation process, and then cannot be separated out of Au seed-deposited IONPs. 
Although this phenomenon was reproducible, it has not been understood fully. We 
hypothesize that the polymer film might be produced from the oxidative self-
polymerization of dopamine [200]–[202].  
For this reason, it is difficult to obtain well-defined IOGNPs after the Au shell growth 
process. Fig. 3.5(b) shows TEM images of core-shell NPs achieved when the HAuCl4 
precursor was reduced. There are some aggregations of Au nanoshells due to cross-
linking between Au shells, but we can clearly see smaller islands and even isolated 
particles. Also, the sample after shell growth shows isolated Au NPs of ca 3-4 nm size 
which are assumed to result from the growth of Au on free Au seeds. Although these 
Au NPs can be removed by magnetic separation, the formation of aggregation is 
difficult to avoid due to the present of impurities of free Au seeds sticking in the 
polymer film. 
Synthesis of IOGNPs from mp-SiO2 functionalized IONPs  
mp-SiO2-coated IONPs were synthesized by the Stöber method in which TEOS was 
hydrolyzed by the reaction with NaOH and the silica shell was grown on top of the 
CTAB/oleic acid bilayer [52]. CTAB plays important roles in the synthesis of MNPs: 
i) it acts as phase transfer agent from the organic to the aqueous phase and ii) as 
template for the formation of pores during growth of the silica shell [181].  
Fig. 3.6(a,b) shows TEM images of oleic acid coated IONPs (8.6 ± 0.6 nm) and mp-
SiO2 coated IONPs (ca. 50 nm). Pores inside the silica shell can be seen clearly in Fig. 
3.6(c). After functionalization, the particles remain superparamagnetic however the 
saturation magnetization is significantly lower than that of oleic acid coated IONPs 
due to increased weight of the core/shell particles (Fig. 3.S3, SI). After 
functionalization of IONPs with a mp-SiO2 shell and then with APTMS, Au seeds 
were decorated on the surface of particles and Au shell growth was carried out by the 
reduction of Au plating solution as illustrated in Scheme 3.4.  
TEM image of Au seed decorated mp-SiO2-functionalized IONPs is shown in Fig. 
3.6(c). Each iron oxide - mp-SiO2 core-shell particle is surrounded by a large number 
of Au seeds due to the large surface of the silica shell. The surface coverage of Au 
seeds is roughly estimated about 30%, which is consistent with results reported 
previously [194], [203]. A minus ZP value of iron oxide-silica-Auseed (-22 mV, see Fig. 
3.S4, SI), also confirms the formation of Au seed attachment. 
By the addition of the Au plating solution and the reductant formaldehyde, HAuCl4 
was reduced  on the Au seeds. As a result, the growth of Au seeds gradually leads to 
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Scheme 3.4: An illustration of the synthesis of iron oxide-mesoporous silica-gold 
multilayer nanoshells.  
 
 
 
  
 
 
 
Fig. 3.6: TEM images of (a) oleic acid coated IONPs, (b) mp-SiO2 functionalized 
IONPs, (c) Au seed-decorated mp-SiO2 functionalized IONPs, (d,e) iron oxide-
mesoporous silica-gold multilayer nanoshells. Scale bar in (a) is 50 nm. All scale 
bars in (b),(c), (d),(e) are 20 nm. 
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the formation of incomplete Au shells and then complete Au shells. Formation of the 
incomplete Au shells are observed in the TEM image (Fig. 3.6d) and also in the SEM 
image (see Fig. 3.S5, SI). Furthermore, Fig. 3.6(e) shows TEM images of Au 
nanoshells when more Au plating solution added. We now clearly observe  the 
formation of cross-linking between particles along with the growth of Au shells. This 
leads to the formation of aggregates and changes the optical properties of the Au 
nanoshells.  
Fig. 3.7 shows UV-Vis spectra of iron oxide-silica-Auseed NPs when gradually adding 
Au plating solution. Their intensity increases because more Au atoms were deposited 
on the surface of the particles, more free electrons on the surface of Au shells 
participate in the LSPR. Moreover, the SP band became broader and the band was red-
shifted (up to ~ 700 nm). The continuous increase of λmax when adding Au plating 
solution suggests that complete nanoshells have not been achieved yet because the SP 
band will be blue shifted when complete Au shells grow thicker [204], [205]. 
In general, IO-Au core-shell NPs were synthesized in aqueous phase with tunable 
plasmonic properties. The gold nanoshells were observed by TEM images while their 
LSPR bands can be red-shifted in NIR region. The core-shell NPs were synthesized 
from amino-terminated functionalized IONPs, in which Au shell growth plays a key 
role in the achievement of the well-defined IO-Au core-shell NPs. Although the results 
are promising, improvement of control of Au shell growth process is needed because 
cross-linking between Au shells was formed as side products, leading to the formation 
of aggregations.  
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Fig. 3.7: UV-Vis spectra of Au nanoshells when adding 1-4 mL of Au plating 
solution to Au seed-decorated iron oxide-silica NPs. 
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3.3.2 Synthesis of IOGNPs in organic phase 
Synthesis of IOGNPs: 
Oleic acid-coated IONPs were also used for the synthesis of IOGNPs in organic phase. 
The TEM image of IONPs was shown in Fig. 3.6a with a size of 8.6 ± 0.6 nm. Fig. 3.8 
shows the TEM image of an iron oxide-gold core-shell NPs which appear much darker 
than the IONPs due to the formation of Au shells. An image analysis shows an overall 
size of around 10.9 ± 0.9 nm, yielding a thickness of the gold shell of 1.2 nm. There 
are a few brighter and smaller nanoparticles in Fig. 3.8, which can be assigned to 
uncoated nanoparticles. Actually, the core-shell structure cannot be seen in the TEM 
image because gold has a higher electron density than IONPs and allow fewer 
electrons to go through [206], [207]. However, the changes in the size and the 
appearance of particles in Fig. 3.8 indicates core-shell formation. Moreover, the study 
of their optical properties also strengthens this hypothesis. 
Fig. 3.9 shows the extinction spectrum of Au-coated IONPs (solid line) in comparison 
with the spectrum of IONPs before the reaction (dashed line). The spectrum indicates a 
 
 
Fig. 3.8: TEM images of Au coated IONPs. An example of coated and uncoated 
NPs is pointed out. The coated and uncoated NPs can be distinguished by the 
contrast of the particles. Scale bar is 20 nm. 
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strong absorption peak centered at 528 nm due to the LSPR response of Au shells. The 
extinction of the gold-coated IONPs increases strongly at short wavelengths due to the 
scattering of nanoparticles.  
The magnetic properties of the Au-coated IONPs were characterized by SQUID 
measurements. The measurements were performed in magnetic fields from -3 to 3 
Tesla at 300 K. Fig. 3.10 shows the magnetization curve of core-shell NPs in 
comparison with the magnetization curve of IONPs performed by VSM measurement. 
The saturation magnetization decreases from 56 emu/g to 9.2 emu/g upon the gold 
coating. This decrease (84%) is very large if we only consider the decrease of 
magnetization due to the increase of magnetic particle weight (29% - calculated). 
Hence, the decrease is not only ascribable to the particle weight increase. There must 
be a contribution from the interaction between the magnetic core and the gold shell.  
There are some reports indicating that direct coating of gold onto IONPs severely 
decreases the saturation magnetization of the magnetic core by 78% or more [23], [33]. 
The mechanism is still being studied however there might be a contribution from the 
migration of gold atoms into the iron oxide core, as suggested by Smolensky [33]. This 
migration would lead to a distortion of the core and therefore decrease of the magnetic 
properties. A similar effect was also discovered when gold was coated on the surface 
of cobalt NPs [208].  
Phase transfer 
Au-coated IONPs were transferred from an organic phase (heptane) to an aqueous 
phase by the interaction of CTAB with the coating layer of oleic acid and oleylamine. 
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Fig. 3.9: Extinction spectra of IONPs and IO-Au core-shell NPs. 
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Because oleic acid binds more strongly to IONPs than CTAB does, no ligand 
exchange occurs. There is formation of oleic acid/oleylamine – CTAB bilayers in 
which hydrocarbon tails of CTAB penetrate the hydrocarbon chains of oleic 
acid/oleylamine and the ammonium heads become exposed to the aqueous medium. 
Fig. 3.11 shows the dispersion of Au-coated IONPs in heptane (left) and in water 
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Fig. 3.10: Comparison of saturation magnetization of iron oxide NPs (VSM 
measurement, dashed line) and saturation magnetization of gold coated iron oxide 
NPs (SQUID measurement, solid line).  
 
  
 
 
 
Fig. 3.11: Dispersion of Au coated IONPs in heptane (left) and in water (right) 
before and after phase transfer. 
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(right) before and after phase transfer. The organic phase turned colorless after phase 
transfer indicating all Au-coated IONPs were successfully transferred to aqueous 
phase. 
After many efforts, well-defined water-dispersed iron oxide-gold core-shell NPs were 
achieved. The particles are spherical, containing a magnetic core with a small standard 
deviation and a thin shell of gold. These core-shell particles can be further 
modified/functionalized and applied in many applications.   
3.3.3 Synthesis of IO-Au-SiO2 NPs  
Iron oxide-gold-mesoporous silica multilayer nanoshells were synthesized from Au-
coated IONPs. The procedure consists of two steps: phase transfer of IOGNPs from 
organic phase to water and mesoporous silica growth by Stöber method. Fig. 3.12 
shows TEM images of IO-Au-SiNPs. An analysis indicates the particle size is 67.4 ± 
7.2 nm. Taking into account that the size of IONPs is 8.6 nm and the size of IOGNPs 
is 10.9 nm, the inner shell thickness of gold shell is 1.2 nm and the outer shell 
thickness of silica is 28.1 nm. 
The addition of mesoporous silica shells onto the IOGNP surface leads to mesoporous 
shells which might be exploited in drug release and delivery, fluorescent labeling, so 
on. These extra potential applications rely on porous silica shells and their ability in 
functionalization with various ligands. For these reasons, IO-Au-SiO2 NPs were 
functionalized with rhodamine B as a test. Fig. 3.13 shows the UV-Vis spectra of IO-
Au-SiO2 NPs (dashed line) and rhodamine B functionalized IO-Au-SiNPs (solid line). 
The spectrum of IO-Au-SiO2 NPs exhibits a LSPR peak centered at 528 nm, indicating 
that the coating layer of silica does not change the optical properties of the gold shell. 
After functionalization, bound rhodamine B shows a strong absorption at 550nm and 
the LSPR band of Au shells still remains in the spectrum as a shoulder.   
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Fig. 3.12: TEM images of IO-Au-SiO2 NPs. 
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Fig. 3.13: UV-Vis spectra of IO-Au-SiO2 NPs , free rhodamine B and rhodamine B 
functionalized IO-Au-SiO2 NPs.  
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3.4 Conclusions 
In summary, we have described two approaches to synthesize iron oxide-gold core-
shell NPs: synthesis in aqueous phase and organic phase. A large batch of highly 
monodispersed oleic acid-coated IONPs (8.6 nm size) was synthesized and these 
particles were used as seeds for all gold coating experiments in this study.  
Synthesis in the aqueous phase started with Au seed deposition onto the surface of 
amino-terminated functionalized IONPs. Then HAuCl4 was selectively reduced onto 
Au seeds by a weak reductant, leading to the formation of Au shells. Moreover,  their 
plasmonic properties are tunable and can be shifted in NIR region. However, further 
studies on Au shells growth control need to be performed in order to achieve 
monodispersed core-shell structures.  
Synthesis in the organic phase resulted in well-defined gold coated IONPs with the 
shell thickness of 1.2 nm. Then, the particles could be transferred from organic phase 
into aqueous phase for biomedical applications. Their plasmonic properties remain 
unchanged but the magnetization of the core-shell structures was intensively 
decreased, mainly due to the immigration of Au atoms into iron oxide core. 
Furthermore, multilayer nanoshells were also synthesized in order to combine all novel 
properties of the magnetic core, the plasmonic shell and the mesoporous silica shell.  
With many interesting properties, magneto-plasmonic core-shell nanoparticles are 
promising candidates for advanced biomedical applications such as noninvasive 
imaging, magnetically guided drug delivery, controlled drug release, targeted 
hyperthermia induced by an external magnetic field or a laser source. Plasmonic 
properties are also interesting for nonlinear imaging and labeling applications.  
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3.5 Supporting information 
A. Experimental section 
All chemicals were purchased from standard suppliers and used as received without 
further purification. Milli-Q H2O (18 MΩ cm
− 1
) was used to prepare all aqueous 
solutions.  
In detail: tetrakis(hydroxymethyl)phosphonium chloride (THPC, 80 % solution in 
H2O) formaldehyde (HCHO, 37 % in water),  Cetyltrimethylammonium bromide 
(CTAB), tetraethylorthosilicate (TEOS), Dopamine hydrochloride (Dop.HCl), sodium 
oleate and iron(III) chloride hexahydrate (97 %) were purchased from Sigma Aldrich. 
Tetrahydrofuran (THF), tetrachloroauric acid (HAuCl4.3H2O), hydrogen chloride 
(HCl, 37 %), sodium hydroxide (NaOH, pellet), sodium dihydrogen phosphate 
(NaH2PO4), potassium carbonate (K2CO3) were purchased from Sigma Aldrich.  
3-Aminopropyltrimethoxysilane (APTMS, 97 %) were obtained from ABCR. 1-
Octadecene (90 %, technical grade) was purchased at Acros. Ethanol (EtOH, absolute) 
and oleic acid were obtained from VWR. Heptane and toluene were obtained from 
Fisher Scientific, and acetone was purchased at Chem Lab.  
 
Preparation of Au seeds 
Au seeds (ca. 2nm) were synthesized following a previously published protocol with 
minor modifications [193]. Firstly, the solution of HAuCl4 was prepared beforehand 
by dissolving 20 mg of HAuCl4.3H2O in 2mL Milli-Q water. This fresh solution need 
to be prepared at least 15 minutes before the reaction [193]. Then, a mixture of 45.5 
mL of Milli-Q H2O and 1.5 mL of 2M NaOH was prepared and vigorously stirred in a 
100 mL beaker. To this solution, 1 mL of H2O and 12 µL of 80% THPC was added. 
After 2 minutes, 2 mL of the HAuCl4 solution was added, leading to the change of 
solution color from yellow to brown after few seconds due to the formation of brown 
hydrosol of gold. The solution was kept stirring in 10 minutes and then stored in a dark 
condition at 4 
o
C. A large quantity of gold sols (up to 300 mL) with similar size can be 
prepared by using the same procedure. 
 
Preparation of PBS buffer solution 
10 mM PBS buffer solutions were prepared from NaH2PO4. pH values of these 
solutions were determined by a pH meter and was adjusted by dilute HCl or NaOH 
solutions. 
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Preparation of HAuCl4 plating solution 
A 0.44 mM HAuCl4 plating solution was prepared from Au precursor (HAuCl4) by 
dissolving 30 mg of HAuCl4 (34.8 mg HAuCl4.3H2O) and 50 mg of K2CO3 in 200.3 
mL of Milli-Q H2O. The plating solution was stored at 4 
o
C for at least 1 day before 
use as recommended by Bruce [100]. 
 
Preparation Au NPs by citrate method 
Gold colloidal synthesis was performed following a method based on an aqueous 
citrate reduction [209]. In a typical protocol, 500 mL of 1 mM HAuCl4 was prepared 
in a 1 L Erlenmeyer flask. The solution was vigorous stirred and heated to boil. When 
the solution boiled, 50 mL of 38.8 mM sodium citrate was added. The yellow solution 
shortly turned clear, dark blue and then a deep red burgundy color. After that, the 
solution was kept stirring and boiling for 10–15 min. Heat source was removed and the 
solution was then kept stirring for 15 min. Finally, the solution was diluted to 500 mL 
with H2O, resulting a deep red colored dispersion. 
 
Synthesis of oleic acid coated IONPs 
Superparamagnetic IONPs were synthesized by the method published previously [75], 
[210]. First iron oleate precursor were prepared from iron (III) chloride and sodium 
oleate, followed by the transformation into IONPs.  
36.5 g (120 mmol) of sodium oleate and 10.8 g (40 mmol) of FeCl3.6H2O were 
dissolved in a mixture of 80 mL ethanol, 60 mL Milli-Q water, and 140 mL heptane. 
This mixture was heated to reflux at 70 
o
C for 4 h under argon protection. Afterward, 
the upper layer containing iron oleate in heptane, was separated using a separatory 
funnel and washed three times with 40 mL Milli-Q water. Then, heptane was 
evaporated using a rotavapor, resulting in a dark brown waxy solid. 
For the synthesis of IONPs, 36 g (40 mmol) of iron oleate precursor, 5.7 g (20 mmol) 
of oleic acid and 200 g of 1-octadecene were added to a 500 mL three-neck flask. This 
mixture was first heated to 100 
o
C for 5 min to evaporate all remaining heptane. After 
fitting a reflux cooler, the mixture was heated further to 320 
o
C and kept at that 
temperature for 30 min. Around 250 
o
C, the decarboxylation of the oleate starts, 
producing a large amount of CO2 gas. After the reaction, the mixture was cooled down 
to room temperature. The precipitation of IONPs was performed by the addition of the 
large amount of ethanol (500 mL). After that, the particles were magnetically 
separated and washed with ethanol. Finally, IONPs were dried in a vacuum and then 
dispersed in heptane (with one drop of oleic acid) at the concentration of 100 mg/mL. 
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Fig. 3.S2: ZP measurement of Au seed-decorated dopamine functionalized IONPs. 
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Fig. 3.S3. Magnetization curves of IONPs and mesoporous silica coated IONPs. After 
the synthesis, the particles retain superparamagnetic behavior. Reprinted from our 
published article, Ref. [52]. 
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Fig. 3.S4: Zeta potential measurement of iron oxide-silica-Auseed NPs. 
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Fig. 3.S5: SEM images of Au seed decorated iron oxide-silica core-shell NPs (top) and 
incomplete Au shells (bottom). 
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Chapter 4 
Magnetothermal release of 
payload from iron oxide/silica drug 
delivery agents 
 
 
 
Dr. M. Bloemen prepared iron oxide nanoparticles. R. Strobbe designed the AC 
magnetic heating setup. J. Jochum performed SQUID measurements. Prof. Dr. J. 
Billen performed TEM measurements.  
This chapter is based on the following publication with minor modifications: 
“Magnetothermal Release of Payload from Iron Oxide/Silica Drug Delivery 
Agents”  
T. T. Luong, S.Knoppe, M. Bloemen,
 
W. Brullot, R. Strobbe,
 
J.-P.Locquet 
and
 
T. Verbiest.  
Journal of Magnetism and Magnetic Materials, 416 (2016) 194-199  
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Abstract 
The release of covalently bound Rhodamine B from iron oxide/mesoporous silica 
core/shell nanoparticles under magnetically induced heating was studied. The system 
acts as a model to study drug delivery and payload release under magnetothermal 
heating. 
4.1 Introduction 
Magnetic nanoparticles are of great interest for researchers from a broad range 
of disciplines, especially in bio-medicine, because of their interesting properties 
such as superparamagnetism, non-toxicity, bio-compatibility, and ability to 
functionalise the ligand shell [63], [151], [211], [212]. Some important bio-
applications are magnetic bio-separation and detection of biological entities 
[67], [211] (such as cells, proteins, nucleic acids, enzymes, bacteria, and 
viruses), clinic diagnosis and therapy (including Magnetic Resonance Imaging, 
MRI, and magnetic hyperthermia) [67], [170], [213]–[215]. 
Among these applications, inducing hyperthermia with magnetic nanoparticles 
is a promising one [216]. Under the influence of external oscillating magnetic 
fields, magnetic nanoparticles can be heated through several loss process such as 
Néel relaxation or Brownian relaxation. This leads to temperature increase of 
the surrounding medium and subsequent death of cancer cells. Cell death can 
occur when the temperature of the region increases above 42 
o
C while necrosis 
occurs at 50 
o
C and above [13]. In order to obtain hyperthermia efficiency, 
magnetic nanoparticles need to be targeted and gathered with high enough 
concentration on the surface of the cancer tumor, and efficient targeting is still 
challenging [217]. 
Recently, controlled dye/drug release has been the focus of many studies [43], 
[164], [218]–[220]. Multifunctional drug delivery systems, especially 
mesoporous nanoshell structures, have received a lot of attention because many 
interesting properties can be combined into one particle [164], [221]. In 
addition, mesoporous silica nanoshells or nanoparticles are known to be 
nontoxic [41], [222]. Silica nanoparticles with uniform shape and size, and well-
defined mesoporous structure were synthesized [223] and they can carry dyes or 
drugs [57], [224], [225]. It is essential for these systems to exhibit a “zero 
release” of payload (under normal conditions) and efficient release under 
external stimuli [220]. To meet the “zero release” requirement, the pores on the 
surface of silica shells are covered by macro cycles [164], polymers [218] or 
small nanoparticles [43], [219] after loading the cargo molecules. Opening of 
these nanocaps can be triggered by chemical and physical stimuli such as pH, 
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disulfide reducing compounds, enzymes, temperature, light, magnetic field 
[220]. The physical stimuli-induced release cannot only be controlled spatially 
and temporally but also has the advantage of avoiding a physical contact or 
chemical reaction with the carrier devices. Although the payload molecules are 
trapped inside mesoporous silica shells and their release is prevented 
considerably by forming nanocaps, it is still a challenge to fully control 
premature payload leakage and stability under physiological conditions. 
In this context, we report the loading of a payload (rhodamine B fluorescent dye 
[181], [226], [227]) by forming a robust covalent bond with iron oxide-
mesoporous core-shell nanoparticles (Scheme 4.1). We studied release of the 
dye via magnetically induced heating. We studied the influence of magnetic 
field strength on the extent of dye release. The release was followed 
photometrically, and the rhodamine B acts as a model for controlled 
magnetically induced dye release from magnetic core/shell nanoparticles. 
4.2 Experimental section 
The synthesis of rhodamine B functionalized iron oxide/mesoporous silica 
core/shell nanoparticles (Rho-MNPs) was carried out following published 
protocols with modifications [75], [181]. Details can be found in the SI. 
A home-made AC magnetic heating setup with a copper coil (n = 42 loops, l = 
0.42 m) was used (Fig. 4.S1, SI). The coil was connected to an AC power 
source, and the amplitude of the magnetic field is determined by equation (1) in 
SI. Release of dye was studied at different magnetic field strengths: 2.4 kA/m, 
Scheme 4.1: Schematic for the preparation of Rho-MNPs. 
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3.6 kA/m, 4.8 kA/m and 6 kA/m (magnetic flux density: 30 G, 45 G, 60 G and 
75 G, respectively) at a frequency of 48 kHz. A centrifugation tube containing 
7.5 mL of Rho-MNPs solution (0.133 mg/mL) was placed in the center of the 
copper coil (Fig. 4.S1, SI). For each magnetic field, the temperature of the bulk 
solution was recorded until equilibration.  
To determine the amount of released dye, aliquots of 0.5 mL were taken over a 
range of up to ten days and diluted three times with ethanol. The solution was 
centrifuged (11,000 rpm, 20 min) and the supernatant was collected and its UV-
Vis spectrum was recorded. To prove that the dye release is induced by 
magnetic heating and not due to temperature increase in the bulk solution, 
control experiments were carried out. In detail, Rho-MNPs were aged at 
different temperature using an oil bath instead of an AC magnetic field as a heat 
source. Otherwise, the samples were processed as described above. 
4.3 Results and Discussion 
Superparamagnetic iron oxide nanoparticles (IONPs) (mainly Fe3O4 with small 
amounts of Fe2O3) were synthesized at large scale as reported earlier [75]. Fig. 
4.S2 in SI shows a TEM image of oleic acid coated IONPs and the histogram of 
particle size distribution (the inset). The particles size is 8.6 ± 0.6 nm. CTAB 
plays important roles in the synthesis of magnetic nanoparticles (MNPs): i) it 
acts as phase transfer agent from the organic to the aqueous phase and ii) as 
template for the formation of pores during growth of the silica shell [181]. To 
form the shells, TEOS was hydrolyzed by the reaction with NaOH and the silica 
shell was grown from ammonium groups of CTAB-IONPs. 
Fig. 4.S3 (SI) shows TEM images of MNPs when changing the concentration 
from 0.275 M to 0.0275 M. In most cases, one iron oxide core was coated by a 
silica shell. Visually, the pore size decreases when the amount of CTAB is 
decreased (Fig. 4.S3a,b,c,d). An analysis of particle size indicates that the size 
of the core-shell nanoparticle is around 50 nm, yielding a thickness of the silica 
shell of ca. 20.7 nm. A CTAB concentration of 0.11 M was used for the 
particles in further experiments. 
Characterization of MNPs by a superconducting quantum interference device 
(SQUID) shows that no coercivity or magnetic remanence is found, indicating 
that the particles remain superparamagnetic (Fig. 4.S4). The magnetization of 
the core/shell particles saturates at ca. 1 Tesla. The saturation magnetization 
(3.86 emu/g) of the core/shell particles is significantly lower than that of oleic 
acid coated IONPs (55 emu/g) [75]. This decrease is assumed to be due to 
increased weight of the core/shell particles. The particles were then 
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functionalized with rhodamine B isothiocyanate (RITC). For this, we first 
reacted RITC with APTES in ethanol as shown in Scheme 1, followed by 
addition of RITC-APTES to a dispersion of the MNPs in toluene. Toluene 
contains enough water to initiate the condensation reaction between the siloxane 
and the silica shell [228]. A photograph of the RITC functionalized MNPs is 
shown in Fig. 4.1.  
When applying an external AC magnetic field to Rho-MNPs, the magnetic 
particles convert magnetic energy to thermal energy and the MSNs are heated 
strongly. Fig. 4.S5a shows the temperature increase of the bulk solution as the 
result of increase of the local temperature surrounding the magnetic particles. 
The starting temperature is 22 
o
C and it reaches saturation after one hour in most 
cases. When the amplitude of the applied magnetic field was varied from 2.4 
kA/m to 6 kA/m, the temperature increase of the solutions (ΔT) increased from 3 
to 17.5 
o
C. The temperature evolution in the bulk solution follows an 
exponential function [229]  (Table 4.S1, SI). A linear correlation was found 
when comparing the temperature increase ΔT as a function of the magnetic field 
H (Fig. 4.S5b, SI). Although the concentration of MNPs was quite low (0.133 
mg/mL), a significant increase of the solution temperature is observed, 
suggesting that the local temperature surrounding the MNPs is very high and 
this thermal energy might be high enough to break down the covalent bonding 
in mesoporous silica shells to release the payload. The average bond 
dissociation enthalpies of C-N, C-Si, C-C are 305, 318, 347 (kJ/mol) 
respectively [230], suggesting that the C-N bond in the thiourea group might be 
broken to release rhodamine B. 
 
Fig. 4.1: Photographs of MNPs solution before (a) and after (b) loading with 
rhodamine B, the solvent is ethanol. c) TEM image of MNPs (a). 
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When the particles are heated by AC magnetic fields, rhodamine B is released 
from the MNPs, hence the absorbance of rhodamine B in the supernatant 
increases. Fig. 4.2 shows the UV-Vis spectra of the supernatants before and after 
heating (H = 6 kA/m) over a time span of four days.  
The concentration of the released dye is straight forwardly calculated from the 
absorbance of the supernatants (Figs. 4.S6 and 4.S7). The determination of the 
concentration of the dye in the nanoparticles is more complex due to scattering 
contributions from iron oxide and silica. We used Gaussian peak fitting of the 
extinction spectra of Rho-MNPs in ethanol to extract the contribution of dye 
absorption (Fig. 4.S8). 
Fig. 4.3 shows the percentage of released dye (with respect to the total amount 
of dye in the nanoparticles). The dye is released faster when exposed to stronger 
magnetic fields. At 6 kA/m, the dye release appears to saturate at about 40 % 
after four days, but slightly drops after continued magnetic heating. This 
decrease is reproducible and might be due to degradation of the dye by high 
local temperatures surrounding the MNPs (see Fig. 4.S11). At lower magnetic 
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Fig. 4.2: Extinction spectra of Rho-MNPs solution (dash line) and released 
rhodamine in the supernatant (solid line) after magnetic heating over four days 
(magnetic field: 6 kA/m). 
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field strengths, less dye is released. The fact that we do not observe complete 
release is likely due to two reasons: 1) at stronger fields the dye might degrade 
before complete release; 2) the silica shell is not completely degraded as seen in 
transmission electron microscopy (Fig. 4.4). Future research could therefore 
focus on improving release by changing the strength of the covalent bond (300 – 
350 kJ/mol for thiourea), the thickness and porosity of the silica shell and the 
magnetic field strength. While this may be detrimental to the stability of the 
payload (see above), we suggest pulsed magnetic field induced heating instead 
of continuous heating. In addition, the dye release may depend on the pH, as it is 
known that the dissolution of mesoporous silica is faster in basic media [231]. 
Hence, under physiological conditions (pH ~ 7.5), dye release could be 
significantly different.  
Note that a strong magnetic field was used in this experiment, causing a high 
solution temperature (39.5 
o
C). Therefore, control experiments using external 
 
Fig. 4.3: Percentage of released dye in different magnetic heating experiments 
and control experiments (without magnetic field). More dye was released when 
increasing the strength of the magnetic field from 2.4 - 6 kA/m (dotted lines). In 
the control experiments (solid lines), even at elevated temperatures, the amount 
of released dye is significantly lower than with magnetically induced heating at 
low fields. Note that the lines are merely a guide to the eye and not a fit to the 
data. 
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heating via an oil bath (solution temperatures of 27.5 – 50 °C) were carried out 
to show that the release is due to heating of the magnetic cores of the 
nanoparticles and not due to temperature increase of the bulk solution. Even at 
elevated temperatures, the absorbance of the supernatant is significantly lower 
than with magnetically induced heating at low fields (Fig. 4.3). 
Using CTAB as templating agent during growth of the silica shell, mesoporous 
shells are obtained. These are known to degrade under heat [232]–[234]. Fig. 4.4 
shows TEM images of MNPs before and after heating at 6 kA/m for six days. 
Clearly, the morphology of the MNPs was modified, caused by the heating of 
the magnetic core. The damage of the silica shells results in an increase of pore 
size. 
The release of rhodamine B into the solution under magnetically induced 
heating is due to the local heating of the superparamagnetic iron oxide cores of 
the core/shell particles. The concentration of dye in the supernatant after 
equilibration scales linearly with the magnetic field strength applied during 
heating (Fig. 4.5, top) It is an obvious question to search for the reaction law and 
a correlation between magnetic field strength and the rate of dye release. In a 
simplified way, the dye release process can be described by the reaction:  
Rho-MNPs  Rhodamine 
This unimolecular reaction might be expected to obey a first order rate law:  
𝑙𝑛(𝐶) = −𝑘𝑡 + 𝑙𝑛(𝐶0) 
Where C is the concentration of the reactant (bound dye, mol/L), C0 is the 
concentration of the reactant at the beginning and k is the rate constant. 
  
Fig. 4.4: TEM images of NPs before heating (a) and after heating at the magnetic 
field of 6 kA/m for 5 days (b). The scale bars are 100 nm (a) and 20 nm (b). 
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Fig. 4.5: (Top) Dependence of the saturation concentration of released dye in 
the supernatant with the magnetic field strength during the magnetically induced 
heating (R
2
 = 0.9748). A good linear correlation is observed. (Bottom) Kinetic 
analysis of unimolecular release reaction. Plot of ln(C) vs. reaction time. No 
linear correlation was found, indicating that the dye release reactions do not 
follow a first-order rate law.  
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However, analysis indicated that there is no linear correlation between ln(C) and 
t (reaction time, seconds) (Fig. 4.5, bottom), and the dye release does not follow 
a classical first order rate law. The absence of a linear correlation indicates that 
the reaction is more complex than a classic first order reaction. This is easily 
imaginable since different processes take place during the dye release upon 
magnetically induced heating: a) breaking of the covalent bond between 
rhodamine B and silica, b) breaking of the mesoporous silica shell, and c) 
diffusion of the payload out of the pores of the mesoporous silica shell to the 
solution. Considering that each of these processes is temperature-dependent and 
follows individual rate laws, it is evident that the overall process (which is 
studied here) does not obey a classic first-order rate law. In addition to that, the 
system was not stirred, which may also impact the reaction kinetics. 
We prefer not to speculate about the individual contributions of these effects, as 
we are currently unable to address these independently. Further, more detailed 
studies are therefore necessary.  
4.4 Conclusions 
In summary, mesoporous silica shells were successfully coated on the surface of 
IONPs and subsequently rhodamine B was grafted to the silica. The dye was 
released under magnetically induced heating. In contrast, little release is 
observed under heating with an oil bath (no release at room temperature). This 
highlights the suitability of covalently bound payload for use in drug delivery. 
The system acts as a model for stimulated release of a payload from a 
superparamagnetic nanoparticle drug carrier. We studied the influence of the 
magnetic field strength on the release. A clear increase in the release was 
observed under stronger magnetic fields. This is ascribed to increased heating of 
the superparamagnetic cores of the drug carrier. In addition, the silica shell 
degrades over the course of magnetic heating. A broad variety of 
functionalization of the silica shell is accessible, allowing for a range of 
payloads to be bound to the nanoparticles. These particles can also be useful for 
the release of two (or more) kinds of molecules. In that case, two (or more) 
different functional groups with different bond strength could be used. Thus, 
each payload could be released at different magnetic field strengths. The use and 
release of fluorescent dyes may also be exploited in simultaneous imaging (e.g., 
in fluorescent or nonlinear optical imaging) and photodynamic therapy [235]. 
Furthermore, the superparamagnetic properties of the carrier can also be 
exploited in MRI and hyperthermia. Overall, the presented platform offers a 
wide range of functionalities. 
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4.5 Supporting information 
A.Experimental Section 
Materials. All chemicals were used as received without further purification. Sodium 
oleate and iron (III) chloride hexahydrate (97 %) were obtained from Sigma Aldrich. 
Oleic acid, ethanol (analytical reagent grade) and ethyl acetate were purchased from 
VWR. HCl (37 %), heptane and toluene were ordered from Fisher Scientiﬁc. Acetone 
was purchased from Chem Lab. 3-Aminopropyltriethoxysilane (APTES) (97 %) were 
obtained from ABCR chemicals. 1-Octadecene (90 %, technical grade), chloroform, 
tetraethylorthosilicate (TEOS), cetyltrimethylammonium (CTAB) were purchased 
from Acros Organics. Sodium hydroxide, rhodamine B isothiocyanate (mixed isomers) 
(RITC) were supplied by Sigma Aldrich. Milli-Q water (18 MΩ cm
− 1
) was used to 
prepare all aqueous solutions. 
Equipment and Characterization. Transmission electron microscopy measurements 
were performed on a 80 kV Zeiss EM-900 using 300 mesh Formvar coated copper 
grids. Distribution data were calculated by ImageJ. UV–Vis Spectrometry was 
performed on a Perkin Elmer Lambda 900 spectrometer. Magnetic properties of the 
nanoparticles were characterized by a superconducting quantum interference device 
magnetometer (SQUID, Quantum Design MPMS XL-5). 
Synthesis of iron oxide@mesoporous silica core-shell nanoparticles. Uniform 
superparamagnetic IONPs were synthesized using the previously reported method by 
Bloemen et al. [75]. Iron oxide@mesoporous silica (Fe3O4@m-SiO2) core/shell 
nanoparticles were prepared by the method published by Kim et al. [181] with 
modifications. 
In a typical procedure, IONPs (12 mg) were dried from heptane solution and dissolved 
in 0.5 mL of chloroform. Simultaneously, 5 mL of 0.11 M aqueous CTAB solution 
was prepared at 35 
o
C and added to the chloroform solution. The mixture was stirred 
vigorously for 2 hours to form a turbid brown solution. Then, the mixture was heated 
up to 61.5 
o
C and kept stirring for 20 min to evaporate completely the chloroform, 
resulting in a transparent dark brown solution. 
After that, the solution was transferred to a 100 mL round flask containing 45 mL of 
water and 0.3 mL of 2 M NaOH solution. The flask was connected to a condenser and 
heated up to 70 
o
C. To the solution, 0.5 mL of TEOS and 3 mL of ethyl acetate were 
consequently added. The reaction completed after 3 hours. After removing ethyl 
acetate from the solution by rotary evaporation, the particles were separated by 
centrifugation and dispersed again in ethanol. This step was repeated several times to 
remove excess reactants. 
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To extract CTAB from the silica shells, 40 µL of HCl 37 % was added to the 
dispersion and stirred at 60 
o
C for 3 hours or shaking overnight. The pH of the solution 
was tested by pH paper and should be around pH 1-2 to avoid dissolving the magnetic 
core [181]. MNPs were separated and washed 3 times and then dispersed again in 20 
mL of ethanol. 
In this experiment, the concentration of CTAB in 5 mL aqueous solution was varied 
from 0.275 M to 0.0275 M to investigate the effect of the amount of surfactant on the 
pore size of the silica shell. 
Binding RITC to mesoporous silica shell. RITC was coupled to APTES before 
binding to m-SiO2 shells as described in Scheme 1. RITC was reacted with APTES 
(molar ratio 1:10) under dark conditions for 2 days according to the literature [181] 
and the stock solution was kept at 4 
o
C. MNPs (12 mg, prepared with a CTAB 
concentration of 0.11 M) were collected from ethanol solution and re-dispersed in 20 
mL of toluene. To this solution, 0.4 mL of RITC-APTES stock solution was added and 
the obtained solution was shaken overnight. Rhodamine B-MNPs (Rho-MNPs) were 
separated by centrifugation (11.000 rpm, 20 minutes). This step was repeated several 
times until the supernatant was colorless and its absorbance in UV-Vis spectrum was 
insignificant. Rho-MNPs were dispersed in 90 mL of ethanol and stored in a freezer. 
The Rho-MNP solution has the typical pink color of rhodamine B (Fig. 4.1b, 
Manuscript) 
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Fig. 4.S1: (top) Schematic for setup of the magnetic heating experiment, (bottom) The 
solution of Rho-MNPs was stored in a centrifugation tube and placed in the center of 
the copper coil. 
 
When a current occurs in the circuit the strength of magnetic field is determined by: 
H =
n.I
l
   (Eq. 4.S1) 
Where: H is the strength of the magnetic field (A/m), n is the number of turns of the 
coil, I is the current (A), l is the length of the coil (m). 
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Fig. 4.S2: TEM image of oleic acid coated IONPs. The inset shows the particle size 
distribution: 8.6 ± 0.6 nm. Scale bar is 50 nm. 
 
Fig. 4.S3: TEM images of m-SiO2 coated IONPs obtained from different synthetic 
batches with various CTAB concentrations: 0.275 M (a), 0.11 M (b), 0.055M (c), 
0.0275 M (d). 
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Fig. 4.S4: Magnetization curves of IONPs and mesoporous silica coated IONPs. After 
the synthesis, the particles retain superparamagnetic behavior. 
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Fig. 4.S5: (Left) Temperature increase of RITC-MNPs solutions when applying a 
magnetic field with different strengths H=2.4, 3.6, 4.8, and 6 kA/m. The temperature 
of the bulk solutions was measured. Analysis of data shows a good fit between the data 
with an exponential function. Right: Plot of ΔT (
o
C) versus magnetic field H (kA/m). A 
linear correlation is found, according to the fact that the applied magnetic fields fall 
within the linear regime of the Langevin-type magnetization curve. 
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Table 4.S1. Exponential fitting of temperature increase of the bulk solution in 
magnetic heating experiment by using model: y = a-b*c
x
 , where: y is the temperature 
increase (
o
C), x is the time (minute) and a, b, c are the parameters of the model. 
H/kAm
-1
 
Adj. R-
Square 
Value 
Standard 
Error 
ΔT(
o
C) (y) 
6 0.9989 
a 18.263 0.336 
17.5 b 18.425 0.415 
c 0.952 0.003 
4.8 0.99597 
a 11.925 0.307 
11.5 b 12.035 0.444 
c 0.943 0.005 
3.6 0.99752 
a 6.808 0.198 
6.5 b 6.852 0.349 
c 0.928 0.009 
2.4 0.99802 
a 3.036 0.151 
3 b 2.989 0.286 
c 0.920 0.018 
 
B. Calculation of the concentration of released dye 
The concentration of the released dye in the supernatant (see manuscript) was 
determined photometrically. For this, we measured a calibration curve of free RITC 
(Fig. 4.S6). Using this calibration curve and the absorbance of released dye at a certain 
moment, we can calculate the concentration of released dye. Note that the solution was 
diluted by factor three before centrifugation. The calculated concentration of released 
dye is shown in Fig. 4.S7. 
 
400 450 500 550 600 650 700
0
1
2
3
 
 
A
b
s
o
rb
a
n
c
e
 (
a
t 
5
5
5
n
m
)
Wavelength (nm)
 0.024 mg/mL
 0.012 mg/mL
 0.006 mg/mL
 0.003 mg/mL
 0.0015 mg/mL
 0.00075 mg/mL
0.00 0.01 0.02
0
1
2
3
 
 
A
b
s
o
rb
a
n
c
e
 a
t 
5
5
5
n
m
Concentration (mg/mL)
R
2
=0.9988
 
Fig. 4.S6: (Left) UV-Vis measurements of free RITC sample with different 
concentrations in Ethanol. (Right) Calibration curve of free RITC in ethanol. A linear 
fit shows the equation y=115.32*x. This equation was used to calculate the 
concentration of the dye in all the samples. 
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Fig. 4.S7: Calculated concentration of released dye in different magnetic heating 
experiments. 
 
C. Calculation of the percentage of released dye. 
It is interesting to determine the percentage of released dye from the nanoparticles 
during magnetic heating. Therefore it is essential to calculate the concentration of the 
dye in the solution before the magnetic heating experiment. As shown in the UV-Vis 
spectra of the solution before heating (Fig. 4.2, manuscript), the absorption is not only 
determined by the dye but also by extinction and scattering of the nanoparticles. To 
calculate the concentration of the dye in the NP solution, the contribution of the NPs 
has to be removed. This removal can be done by two methods: i) peak fitting and ii) 
dissolving silica shell by reaction with NaOH.  
i) Peak Fitting 
The scattering contribution can be estimated by analyzing the UV-Vis spectrum. The 
spectrum of the solution shows a peak at 555 nm, a shoulder at 524 nm, and a 
scattering signal with high intensity at the short wavelength region. Hence, there are 
three peaks used for the fitting: peak 1 (at 555 nm) and peak 2 (at 524 nm) are from the 
contribution of Rhodamine B, peak 3 (in the UV with very board FWHM) is from the 
contribution of the scattering of the nanoparticles. The cumulative fit peak is likely 
coincident with the spectrum of the solution, indicating that a good fit is found (Fig. 
4.S8). To calculate the concentration of RITC in the NPs based on the fit peaks above, 
a new calibration curve based on fitted peaks from the dye is needed.  
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Fig. 4.S8: A peak analysis of the UV-Vis spectrum of the solution before heating (at 6 
kA/m magnetic field). The spectrum of the solution shows a peak at 555 nm, a 
shoulder at 524 nm, and a scattering signal with high intensity at the short wavelength 
region. Hence, there are 3 peaks used for the fitting: peak 1 (at 555 nm) and peak 2 (at 
524 nm) are from the contribution of the dye rhodamine B, peak 3 (far away in the UV 
light with very broad FWHM) is from the contribution of the scattering of the 
nanoparticles. Peak 3 is not shown. 
 
ii) Dissolving the silica shell by reaction with NaOH 
50 µL of 2M NaOH was added to the solution of Rho-MNPs and the solution was 
placed on a shaker for 16 h (room temperature) to dissolve the silica shell. After the 
reaction, the magnetic cores were removed by centrifugation whereas the dye 
remained in the supernatant. The absorbance of the dye was measured and is shown in 
Fig. 4.S9. 
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Fig. 4.S9: UV-Vis spectra of rhodamine B covalently bound with NPs (black) and 
rhodamine B releasing from NPs by adding NaOH to dissolve silica shell (red). 
 
 
There is a good agreement between the calculated concentrations of the dye in Rho-
MNP solution using the two methods. By using the method i, the calculated 
concentration of the dye is 0.0027 mg/mL, and is 0.00253 mg/mL when using method 
ii.  The percentage of released dye after magnetic heating was calculated from this 
initial concentration (0.0027 mg/mL) and is presented in Fig. 4.S10. 
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Fig. 4.S10: (Left) % released dye in the magnetic heating experiments. (Right) Linear 
correlation between % released dye after equilibration and the magnetic field strength. 
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Fig. 4.S11: Magnetic heating experiment at 6 kA/m was repeated to verify the 
phenomenon that percentage of released dye reached maximum after ca. 4 days and 
then decreased. 
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Chapter 5 
Magneto-fluorescent nanoparticles 
for nonlinear optical imaging 
 
 
 
Author prepared nanoparticles and samples for nonlinear measurements. Dr. S. Van 
Cleuvenbergen performed 2-PF, HRS and TPF spectroscopy measurements. C. 
Verstraete performed SHG and 2-PF microscopy measurements. Analysis was done by 
author with the help from Dr. S. Van Celuvenbergen.  
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Abstract 
We investigated rhodamine B functionalized magnetic iron oxide-mesoporous silica 
core-shell nanoparticles (Rho-MNPs) for fluorescence applications. Rho-MNPs 
combine strong fluorescent properties of the dye with superparamagnetic properties of 
the iron oxide core. Nonlinear optical (NLO) spectroscopy measurements moreover 
show promising NLO properties. Strong multiphoton fluorescence signals can be 
attributed to the rhodamine B dye. While the second-order NLO response is rather 
weak, the third-order NLO signal is strong. Indeed the second-order 
hyperpolarizability γZZZZ  is an order of magnitude higher than the benchmark 
chromophore β-carotene. These results highlight the potential of hybrid MNPs for 
multimodal imaging applications. 
Key words: magneto-fluorescent nanoparticles, non-linear optics, imaging, iron oxide-
silica core-shell NPs 
5.1 Introduction 
In recent years multifunctional nanomaterials have been widely studied as promising 
candidates for biomedical applications, e.g., drug delivery, controlled drug release, 
molecular imaging, nanomedicine, clinic diagnosis and therapy [5], [52], [220], [236]–
[240]. In such applications, a wide variety of organic and inorganic nanoparticle 
formulations can be used as a basis for a functional system, e.g., polymers, silica, gold, 
magnetic nanoparticles. In particular, iron oxide based multifunctional nanoparticles 
were admitted as a class of advanced materials due to their ability to interact with 
external magnetic fields [59], [146], [240]. Iron oxide nanoparticles (IONPs) are often 
coated with a silica shell to provide high colloidal stability, biocompatibility and 
versatile surface functionality [59], [241]. Syntheses of IONPs and mesoporous silica 
shells with uniform and tunable size are readily achieved nowadays [52], [75], [181]). 
Loading these iron oxide-mesoporous silica core-shell nanoparticles with high 
concentrations of fluorescent molecules renders magneto-fluorescent nanoparticles 
(MFNPs) that can be employed in advanced applications for diagnosis (multimodal 
imaging) and/or therapy[241]–[244].  
The typical method to form MFNPs relies on the loading of fluorescent components 
(fluorescent dye/polymer, quantum dot) onto the surface of (functionalized) IONPs 
[226], [241], [242], [244], resulting in rather low concentrations of fluorescent 
component on the outer surface. The growth of mesoporous silica shells on IONPs can 
overcome this limitation since the available mesoporous surface is much larger and the 
dye can be loaded on the outer surface as well as inside the pores[52]. 
M a g n e t o - f l u o r e s c e n t  N P s  f o r  N L O  i m a g i n g |  1 1 3  
 
While targeted and non-targeted MRI contrast agents based on superparamagnetic 
property of IONPs were studied a lot before (some of them even became commercial) 
[59], [237], nonlinear imaging applications of magnetic NPs have not yet gained 
attention. Considering the massive number of studies on MNPs reported so far [5], 
[220], [236]–[240] and the advantages of nonlinear optical (NLO) imaging techniques 
this approach can be of importance. Compared with traditional imaging techniques 
NLO imaging provides deeper penetration depths and less photodamage since most 
biological materials are transparent in the wavelength region where multiphoton 
excitation takes place (near-infrared and infrared region) [245], [246]. Additionally 
NLO imaging provides better resolution and enhanced imaging contrast [245]. While 
second harmonic imaging strongly relies on symmetry (the second-order response 
vanishes for centrosymmetric media), multiphoton fluorescence and third harmonic 
imaging are always allowed. Combining different modalities can further improve 
sensitivity, contrast and specificity. Although NLO properties of plasmonic NPs have 
been extensively studied [247]–[252], only few non-systematic studies have been 
carried out regarding the NLO properties of MFNPs [253].  
In this work, we investigate the potential of rhodamine B functionalized iron oxide-
mesoporous core-shell nanoparticles (Rho-MNPs) for NLO applications. NLO 
spectroscopy measurements of two photon fluorescence (2-PF), hyper-Rayleigh 
scattering (HRS) and third-harmonic scattering (THS) were performed at illumination 
wavelengths in the near-infrared region (840 and 1300 nm). The material shows a 
strong 2-PF signal, while both the first and second hyperpolarizability are in the range 
of the best known organic chromophores, while maintaining its superparamagnetic 
properties as evidenced by SQUID measurements. This highlights the possibility of 
using Rho-MNPs as multimodal nonlinear imaging agents and labels for 2PF, second-
harmonic generation (SHG) and THG microscopy. As a test, two photon microscopy 
measurements (SHG and 2PF) were performed and clear images of particles were 
observed.  
5.2. Experiments 
5.2.1 Synthesis of rhodamine B functionalized iron 
oxide/mesoporous silica core/shell nanoparticles 
The synthesis of IONPs was performed following a previously published protocol 
[75]. Synthesized IONPs are stabilized by a coating layer of oleic acid. Core-shell 
nanoparticles, consisting of iron oxide (core) and mesoporous silica (shell), were 
synthesized and then functionalized with a fluorescent dye (rhodamine B) according to 
another published protocol [52]. Cetyltrimethylammonium bromide (CTAB) was used 
as a template to form silica pores.  
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Note that all oleic acid coated IONPs using in this dissertation are from the same 
batch. Mesoporous silica coated IONPs and Rho-MNPs used in this chapter is from the 
same batch with particles used in Chapter 4.  
5.2.2 Nonlinear optical spectroscopy measurements 
NLO spectroscopy measurements in solution were performed using a femtosecond 
laser source tunable from 680 to 1300 nm (Insight DS+, Spectra Physics). The 
intensity is controlled by a half wave plate/ polarizer (S-out) combination. The light is 
then focused in a cuvette by an aspheric lens (f=8 mm) mounted on a computer 
controlled high precision translation stage to compensate for differences in focal length 
due to different wavelengths and/or solvents being used. The light generated in the 
focal volume is then coupled into a spectrometer (Bruker 500 ISM) by a pair of 
achromatic doublets (f1=30 mm, f2=200 mm) while the laser light is filtered out by 
appropriate band pass filters. A spectrum is read out by an EM-CCD camera (Andor, 
Ixon 897) operated in CCD mode. The input power is kept at 400 mW for all 
experiments. For the THS experiments the slit of the spectrometer was fully opened. 
This enhances sensitivity but also leads to broadening of the peaks. 
5.2.3 Nonlinear optical microscopy measurements 
The two-photon microscopy samples were prepared by drop-casting the nanoparticles 
(0.3 mg/mL) in water on microscopy slides, after which the samples were allowed to 
dry for several hours. Two-photon microscopy experiments were conducted on a 
commercial Olympus BX61WI-FV1200-M system (Olympus, Münster, Germany). 
The fundamental wavelength was set to 800 nm or 1100 nm (120 fs pulse width, 82 
MHz pulse repetition rate) on the Deep see Insight DS+ laser of Spectra Physics. The 
polarization of the fundamental beam was controlled using a Glan-laser polarizer. For 
detection at 400 nm, a 425 lpxr dichroic mirror of Chroma was installed in front of the 
detector to collect the two-photon fluorescence signal and an ET 400/10 bandpass 
filter (Chroma) for the SHG-signal. For detection at 550 nm, a 560 lpxr dichroic mirror 
and ET 550/10 bandpass filter of Chroma were used. Detection was carried out non-
descanned in backward reflection using a photon counter detector of Hamamatsu 
R3896 (Hamamatsu Photonics Co., Hamamatsu, Japan). The images (640 × 640 
pixels) were recorded with a 15× Thorlabs LMV objective (NA of 0.35) and a pixel 
dwell time of 200 ms.  
5.2.4 Magnetization measurement  
Magnetic properties of the nanoparticles were characterized by a superconducting 
quantum interference device magnetometer (SQUID, Quantum Design MPMS XL-5). 
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5.3 Results and discussion 
5.3.1 Characterization of nanoparticles 
Characterization of materials by TEM, UV-Vis spectroscopy and SQUID 
measurements show results consistent with those reported in Chapter 4 [52]. 
Fig. 5.1 shows a TEM image of oleic acid coated IONPs (left) and a TEM image 
of iron oxide-mesoporous silica core-shell nanoparticles (right). Note that all 
oleic acid coated IONPs using in this dissertation are from the same batch. An 
analysis of particle size indicates that the size of IONPs is 8.6 ± 0.6 nm (Fig. 
4.S2, SI, Chapter 4) and the core-shell nanoparticle size is 58.0 ± 3.8 nm, 
yielding a thickness of the silica shell of 24.7 nm. Most core-shell particles 
contain one iron oxide particle at the core. SQUID measurements indicate that 
the core-shell particles remain superparamagnetic since no coercivity or 
magnetic remanence is found (see Fig. 4.S4, SI, Chapter 4).  
UV-Vis spectra of free rhodamine B and Rho-MNPs at the same concentration of the 
dye (c=18.37 µM, solvent ethanol) are shown in Fig. 5.2. The spectrum of Rho-MNPs 
shows a peak at 555 nm. There is a small red-shift in comparison with that of the free 
dye, that can be attributed to the interaction of the dye with the silica shell, resulting in 
a change in electronic structure of the dye. 
5.3.2 Two-photon fluorescence (2-PF) spectroscopy 
The laser source was operated at 1110 nm to match the two-photon excitation with the 
absorption of rhodamine B (λmax, EtOH=555 nm, λemission=568 nm [254]). Rhodamine B 
  
Fig. 5.1: (left) TEM image of oleic acid coated iron oxide nanoparticles (8.6 ± 
0.6 nm) (scale bar 50 nm) and (right) iron oxide/mesoporous silica core/shell 
nanoparticles (58.0 ± 3.8 nm) (scale bar 20 nm). 
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functionalized MNPs display a strong two-photon fluorescence (2-PF) signal. Since 
the iron oxide core and silica are non fluorescent themselves [236], the 2-PF can be 
attributed exclusively to the payload, as can also be deduced from the spectral features. 
In Fig. 5.2 the 2-PF signal of free rhodamine B is compared with that of the 
functionalized MNPs, with the rhodamine B concentration equal for both samples. We 
observe a small red shift (from 566 to 571 nm) upon functionalization consistent with 
the UV-Vis spectra.  
A 5-fold decrease in 2-PF intensity is evident, and is most likely explained by 
fluorescence quenching by the magnetic core and/or by the silica shell. Fluorescence 
quenching in the presence of IONPs was observed before [255], [256], however the 
mechanism is not entirely clear as both static (e.g., equilibrium complexation) and 
dynamic (e.g., collisional) mechanism occur. Fluorescence quenching was also 
observed in the presence of a silica shell due to the proximity of dye molecules to the 
shell [253], [257]. 
During 2-PF measurements, the fluorescence intensity was stable, allowing materials 
to be used in imaging or labeling applications. This high stability is an advantage 
compared with fluorescence dyes with short fluorescence lifetimes [253], [257].  
5.3.3 Hyper-Rayleigh scattering spectroscopy 
The use of MNPs as potential second-harmonic labels relies primarily on their first 
hyperpolarizability β. Hyper-Rayleigh scattering (HRS) is a powerful method for 
measuring β of molecules [258], [259] or nanoparticles [247], [248] in solution. We 
measured βHRS  of functionalized and unfunctionalized MNPs at 1260 nm and found 
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Fig. 5.2: Extinction spectra (left) and 2-PF (right) of free and bound rhodamine B for  
an equal concentration of rhodamine B (solvent ethanol). 
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high values of (20±3) × 10
-27 
esu and (21 ± 3) × 10
-27
 esu respectively, by comparing 
the spectra of solutions of known concentration and comparing the second harmonic 
intensity with that of the bare solvent reference (βHRS ethanol,1260 nm = 0.57 × 10
-30
 esu, 
corrected with two-level model [260]). Both values are within experimental error 
identical, indicating that the response stems from the particles themselves rather than 
the dye loaded in the shell. The value of unbound rhodamine B was also evaluated in 
the same manner and was found to be much lower as expected, adding up to (120 ± 
20) × 10
-30 
esu on resonance at 840 nm (or βHRS rhodamine B,1260 nm = (280 ± 42) × 10
-30
 esu 
as calculated by using two level model) . This low value of unbound rhodamine B 
explains why the second harmonic signal is unaffected by the presence of the loaded 
silica shell.  
Since the hyperpolarizability is strongly size-dependent, it is often normalized to the 
number of electrons or atoms. For nanoparticles, the figure of merit is calculated as 
β
2
/atom, hence the actual value of first hyperpolarization for metal nanoparticles is β’= 
β
√𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑡𝑜𝑚
 : β’Ag=(5600 ± 1100) × 10
-30
 esu, β’Au= (2800 ± 500) × 10
-30
 esu [247], 
[248]. For 8.6 nm Fe3O4 nanoparticles the total number of atoms is 5208 (2232 Fe 
atoms and 2976 O atoms), which makes β’= (0.78 ± 0.11) × 10
-30
 esu. Due to the 
absence of plasmonic effects in Fe3O4 nanoparticles, the values obtained here are 
substantially lower. However, if we compare with organic chromophores, this value is 
in the range of the best known organic NLO dyes [258], [261]–[263].  
5.3.4 Third harmonic scattering (THS) spectroscopy 
To evaluate the third-order NLO properties of MNPs third harmonic scattering was 
evaluated at an excitation wavelength of 1300 nm. A strong signal is generated both by 
the functionalized and the bare MNPs at an identical concentration of 1.68 × 10
-16
 
particles/L (see Fig. 5.4). As a reference a solution of pure ethanol, with a known 
second hyperpolarizability γZZZZ of 2.71 × 10
-36 
esu [264] was used to estimate the 
γZZZZ of the MNPs analogous with the calculation of the first hyperpolarizability β.  
We found that γZZZZ of the bare and functionalized MNPs were identical within error, 
i.e. (93 ± 10) × 10
-33 
esu and (98 ± 10) × 10
-33
 for the functionalized and the bare 
MNPs respectively. The strong THS signal can hence be attributed to the MNPs, since 
the presence of rhodamine B does not have a significant effect on the second 
hyperpolarizability. The small difference between both can be attributed to 
reabsorption of THS by rhodamine or multiple scattering by the silica shell. The 
second hyperpolarizability of the MNP is one order of magnitude larger than that of 
the benchmark chromophore β-carotene (10 × 10
-33 
esu, measured on-resonance) [265] 
and much larger than that of π-conjugated polyacetylene or silicon-ring oligomers with 
the same double bonds (12 double bonds, γZZZZ ~ 60 × 10
-36
 esu [266]). This highlights 
their potential to be used as third harmonic imaging labels. 
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Fig. 5.3: Hyper-Rayleigh Scattering spectroscopy of MNPs (top), Rho-MNPs 
(middle) and the solvent ethanol (bottom). The fundamental wavelength is 1260 
nm.  
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5.3.5 Nonlinear optical microscopy 
SHG and 2-PF microscopy measurements of Rho-MNPs were performed at 800 and 
1100 nm. Fig. 5.5 shows images of 2PF and SHG at the wavelength 1100 nm. The 
SHG signal strength is overall negligible or weak, only a few larger droplets are 
clearly visible in the SHG image (Fig. 5.5). The SHG signal strength fundamentally 
relies on both the molecular (microscopic) efficiency of the chromophore, and the 
macroscopic organization of the bulk medium. The latter requirement precludes SHG 
in centrosymmetric materials within the electric dipole approximation. The normalized 
hyperpolarizability (β’= 
β
√𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑡𝑜𝑚
 ) of the Rho-MNPs, though lower than that of 
Au and Ag, is quite high, but spherical particles tend to form isotropic aggregates 
which quenches the SHG signal of the droplets. Small deviations from 
centrosymmetry and symmetry breaking at surfaces can lead to measurable signal in 
some larger particles. In contrast, 2-PF was easily detectable in the droplets found on 
the microscopy slide not having the strict symmetry requirements associated with 
SHG. Other measurements at 800 nm gave similar results.  
The samples were also exposed to high power laser light for longer periods to see if 
there was any photobleaching. We selected a specific area in the 2-PF image and the 
light intensity was recorded over time as shown in Fig. 5.6. The measured signal was 
stable, confirming that no photobleaching occurred for the experimental conditions 
used here (laser power 200 mW – fundamental wavelength 1100 nm).   
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Fig. 5.4: THS of bare and functionalized MNPs for identical concentrations. 
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Fig. 5.5: SHG (top) and 2-PF (bottom) microscopy images of Rho-MNPs samples 
performed at 1100 nm. Particles are found in the 2PF image, however they are not 
found in the SHG image.   
 
M a g n e t o - f l u o r e s c e n t  N P s  f o r  N L O  i m a g i n g |  1 2 1  
 
 
 
               
0 20 40 60 80 100 120
0.00E+000
5.00E+008
1.00E+009
1.50E+009
2.00E+009
2.50E+009
3.00E+009
 
 
In
te
n
s
it
y
Time (s)
 2-PF (area 1)
 2-PF (area 2)
 
Fig. 5.6: (Top) Two areas of image were chosen for the study of photobleaching. 
(Bottom) Intensity of 2-PF signals coming from area 1/area 2 where particles are 
present/absent. Measurements were performed at a fundamental wavelength of 
1100 nm. 
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5.3. Conclusions 
In summary, rhodamine B functionalized iron oxide-mesoporous silica NPs were 
synthesized maintaining their superparamagnetic properties. A well-defined core-shell 
structure was evident from TEM images. We investigated the NLO properties (2-PF, 
HRS, THS) of these core-shell nanoparticles. Functionalization with rhodamine B 
results in strong 2-PF signal when excited at 1100 nm. We also measured the first and 
second hyperpolarizability and found high values comparable or higher than with the 
best organic chromophores.  We conclude that MFNPs have potential to be used as 
labels in nonlinear imaging applications in the infrared region, which is particularly 
interesting for biological deep tissue imaging. Furthermore, the iron oxide core 
provides additional functionality, and can be exploited for MRI, magnetothermal 
heating, drug release, drug delivery and theranostic applications.  
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Chapter 6 
Conclusions and outlook 
6.1 Conclusions 
In general, the functionalization of IONPs with a wide range of capping agents and 
their potential applications were presented in this doctoral research. Thanks to tireless 
efforts of our colleagues before, low-cost, highly reproducible and well-defined IONPs 
were already available [63], [75]. This work focused on the development of the surface 
functionalization. Various small molecules (e.g., PEG-silane, carboxyl-terminated-
PEG-silane, APTMS, dopamine) and inorganic shells (gold, mp-SiO2) were used as 
coating agents to form a versatile platform of functionalized NPs. These coating agents 
provide highly colloidal stability and functional groups for IONPs. We also separately 
explored the abilities of the NPs in bio-entities binding, non-linear imaging and drug 
delivery and release. These abilities are crucial for particles to be used in theranostic 
nanomedicines – in which the particles act simultaneously as a diagnostic and a 
therapeutic agent. 
In Chapter 2 we presented the synthesis of a series of carboxyl functionalized magnetic 
NPs. The particles showed a good colloidal stability whereas the functional group 
carboxyl allowed coupling with bio-entities in the presence of EDC/NHS. The protein 
BSA was chosen as a case study, and the amount of bound protein was quantified by 
Bradford assays.  
Although only BSA is used in this coupling study, it is likely that the procedure can be 
applied for other bio-entities as long as they have free amino groups on the surface. A 
typical example is the preparation of antibodies bound to NPs using the same method 
[67]. Note that this kind of conjugation plays an important role in tumor targeting 
agents in cancer diagnostic or treatment as mentioned in the Section 1.2. Moreover, 
thanks to the superparamagnetic properties of the core, the system also can be used in 
magnetic separation for bio-entities. 
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In Chapter 3 we described two approaches to synthesize IOGNPs: synthesis in aqueous 
phase and organic phase. The obtained particles can be dispersed in water, possess 
both magnetic and plasmonic properties but the magnetization of the core-shell 
structures was severely decreased. Furthermore, multilayer nanoshells were also 
synthesized in order to combine all properties of the magnetic core, the plasmonic 
shell and the mesoporous silica shell. 
The presence of Au nanoshells provides more possibilities in bio-entity coupling 
because Au has high affinity for biological molecules. The study also showed 
promising optical properties of the nanoshells. The SPR bands are tunable and it is 
possible to shift them to the NIR region which can be exploited in deep tissue 
noninvasive imaging and photon-induced hyperthermia. Together with the 
hyperthermia activated by a laser source, magnetic MuNPs can generate heat when 
exposing them to an AC magnetic field. This property can be exploited in magnetically 
triggered drug release which is presented in Chapter 4. 
In Chapter 4, we show a new case study of drug release. A payload (a fluorescent dye- 
rhodamine B) was covalently bound to mp-SiO2 coated IONPs and then was released 
under magnetically induced heating. A well-defined core-shell structure was evident 
from TEM images. In the presence of an AC magnetic field, the iron oxide core was 
strongly heated. This led to a high temperature increase surrounding the core which is 
sufficient to break the bonds between the payload and the particles. We also studied 
the influence of the magnetic field strength on the release. A clear increase in the 
release was observed under stronger magnetic fields.  
The release of a covalently bound payload is the new aspect of dye release. Moreover, 
a broad variety of functionalization of the silica shell is accessible, allowing for a 
range of payloads to be bound to the nanoparticles. The results suggest that these 
particles can also be useful for the release of two (or more) kinds of molecules. In that 
case, two (or more) different functional groups with different bond strength could be 
used. Thus, each payload could be released at different magnetic field strengths. 
Chapter 5 shows the utilization of magneto-fluorescent nanostructures as nonlinear 
imaging agents. We investigated the NLO properties (2-PF, HRS, THS) of these core-
shell nanoparticles. Functionalization of iron oxide- mp-SiO2 NPs with Rhodamine B 
results in strong 2-photon fluorescence signal at 1100 nm. We also measured the first 
and second hyperpolarizability and found high values comparable or higher than with 
the best organic chromophores. We conclude that MFNPs have potential to be used as 
labels in nonlinear imaging applications in the near-infrared region, which is 
particularly interesting for biological deep tissue imaging. 
In conclusion, the presented iron oxide based multifunctional NPs offer a wide 
range of functionalities, which will lead to many future research in biomedical 
applications.  
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6.2 Outlook 
In this section, we discuss the recommendations for future research. Regarding to 
synthesis protocols, even though versatile iron oxide based MuNPs were synthesized 
successfully, several critical steps in the synthesis can be optimized to improve the 
efficiency of potential applications. For example, superparamagnetic IONPs 
synthesized from thermal decomposition method exhibited as great nanocores in the 
formulation of MuNPs, however their magnetization, can be improved by changing 
reaction parameters. This renders MuNPs more advantages, especially in applications 
in which the bioseparations are required. The control of gold shell growth in aqueous 
medium also needs to be improved in order to achieve well-defined IOGNPs with SPR 
band red-shifted to NIR region. This property will supplement their potential in the 
biological deep tissue imaging, besides nonlinear optical imaging as described in 
Chapter 5.  
Iron oxide based MuNPs have great potential in biomedical applications and several 
applications of these nanostructures were explored through the dissertation. More 
future studies in specific applications were also suggested in the Section 6.1. Here, we 
discuss the potentiality of MuNPs as theranostic nanomedicines. Fluorescent dye-
tagged spherical multilayered nanoshells were synthesized in Chapter 3. Moreover, 
MuNPs exhibited their ability in NLO imaging applications in the near-infrared region 
as described in Chapter 5. These techniques provide deeper penetration depths and 
therefore can be utilized in living cell tracking and photon-induced hyperthermia. In 
addition, the magnetically induced hyperthermia also can be achieved due to the 
presence of iron oxide cores, leading to the potential of controlled drug release and 
hyperthermia treatment (see Chapter 4).  For these reasons, iron oxide based MuNPs 
are expected to be the first generation of nanomedicines for human therapy in the near 
future.  
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Health, safety and environment 
 
Regarding the experiments related to this dissertation, all health and safety guidelines 
and regulations from the HSE department of the KU Leuven were obeyed. All 
personal protection (gloves, (laser) safety goggles, lab coat,…) are mandatory. Risk 
analyses and proper waste management were evaluated before every experiment and 
were submitted to the appropriate channels. 
It is highly recommended to follow MSDS (material safety data sheet) before setting 
up any lab experiment. All unattended experiments were considered carefully and 
needed to be approved by HSE department beforehand.  
Following HSE department, there are 4 risk types of danger: E4 (very dangerous), E3 
(dangerous), E2 (moderately dangerous) and E1.  
There are some toxic solvents used in the experiments, such as CHCl3 (E4), toluene, 
ethanol, ethyl acetate (E3). Besides, most of substances are classified as E2 (THPC, 
TEOS) and there is only HAuCl4.3H2O that is classified as E3. HAuCl4.3H2O may 
cause severe skin burns and eye damage and may cause an allergic skin reaction.  
About the toxicity of NPs, although there are some studies about the toxicity of 
particular NPs reported, the studies are not complete [165], [267]. Moreover, the 
toxicity of NPs also depends on their functionalization. However, in general, iron 
oxide, gold and silica NPs are considered as less toxic and biocompatible. For the 
storage, the particles were kept in suspension to minimize exposure.  
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